Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nitric-oxide synthase activity	NOS1 NOS2 NOS3	2.88e-06	3	285	3	GO:0004517
GeneOntologyMolecularFunction	cell adhesion molecule binding	TRPC4 OBSCN CDH23 CDHR5 ITGAD ITGAV TENM2 TWF1 DST CGN TLN2 NOS2 NOS3 ABI1 MYOT LAMA5 CPE CDH19 USO1 TLN1 BCAM TNXB CDH10 CDH15	5.84e-06	599	285	24	GO:0050839
GeneOntologyMolecularFunction	tetrahydrobiopterin binding	NOS1 NOS2 NOS3	1.14e-05	4	285	3	GO:0034617
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA4 MYH13 MYO7B ABCA13 PSMC4 MYO3B MLH1 CHD6 RFT1 TAP1 TAP2 DYNC1H1 SLC27A5 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 HELZ2	2.67e-05	614	285	23	GO:0140657
GeneOntologyMolecularFunction	FMN binding	NDOR1 NOS1 NOS2 NOS3	6.46e-05	16	285	4	GO:0010181
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA4 ABCA13 PSMC4 MLH1 CHD6 TAP1 TAP2 DYNC1H1 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 HELZ2	6.94e-05	441	285	18	GO:0016887
GeneOntologyMolecularFunction	calcium ion binding	TRPM2 CDH23 CDHR5 TENM2 ITPR2 FAT1 DST CPNE1 FER1L5 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CASQ2 CDH19 EFHC2 TGM3 EYS CELSR1 GUCA1C HMCN1 CDH10 CDH15	7.82e-05	749	285	25	GO:0005509
GeneOntologyMolecularFunction	ABC-type peptide antigen transporter activity	TAP1 TAP2	2.03e-04	2	285	2	GO:0015433
GeneOntologyMolecularFunction	tapasin binding	TAP1 TAP2	2.03e-04	2	285	2	GO:0046980
GeneOntologyMolecularFunction	arginine binding	NOS1 NOS2 NOS3	2.27e-04	9	285	3	GO:0034618
GeneOntologyMolecularFunction	nitric-oxide synthase binding	DNM1 NOS2 NOS3 ARG2	2.43e-04	22	285	4	GO:0050998
GeneOntologyMolecularFunction	beta-catenin binding	TRPC4 CDH23 CDHR5 NOS2 NOS3 CDH19 CDH10 CDH15	3.30e-04	120	285	8	GO:0008013
GeneOntologyMolecularFunction	pyrophosphatase activity	NUDT18 ABCA4 ABCA13 TRPM2 PSMC4 GUF1 MLH1 CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10	4.41e-04	839	285	25	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	NUDT18 ABCA4 ABCA13 TRPM2 PSMC4 GUF1 MLH1 CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10	4.48e-04	840	285	25	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	NUDT18 ABCA4 ABCA13 TRPM2 PSMC4 GUF1 MLH1 CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10	4.48e-04	840	285	25	GO:0016818
GeneOntologyMolecularFunction	calcium channel activity	TRPC4AP TRPC4 TRPM2 ITGAV ITPR2 PKD1 TRPC7 CACHD1	5.36e-04	129	285	8	GO:0005262
GeneOntologyMolecularFunction	ADP-D-ribose binding	TRPM2 MACROH2A1	6.03e-04	3	285	2	GO:0072570
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCA4 ABCA13 PSMC4 GUF1 MLH1 CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP DDX12P KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10	7.87e-04	775	285	23	GO:0017111
GeneOntologyMolecularFunction	inositol 1,4,5 trisphosphate binding	TRPC4 ITPR2 TRPC7	9.32e-04	14	285	3	GO:0070679
GeneOntologyMolecularFunction	ABC-type peptide transporter activity	TAP1 TAP2	1.20e-03	4	285	2	GO:0015440
GeneOntologyMolecularFunction	cadherin binding	TRPC4 OBSCN CDH23 TWF1 CGN NOS2 NOS3 ABI1 CDH19 USO1 TLN1 CDH10 CDH15	1.24e-03	339	285	13	GO:0045296
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CADM4 CDH23 CDHR5 FAT1 PKD1 NECTIN4 PCDH10 MYOT DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 HMCN1 CDH10 CDH15	1.28e-10	187	285	18	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CADM4 CDH23 CDHR5 TENM2 FAT1 SLITRK2 PKD1 NECTIN4 PCDH10 MYOT DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 HMCN1 MDGA1 CDH10 CDH15	2.89e-09	313	285	21	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	RIPOR2 CADM4 RC3H1 PIEZO1 CDH23 CDHR5 ITGAD ITGAV TENM2 MALT1 FAT1 SLITRK2 PKD1 PKHD1 NECTIN4 TLN2 PCDH10 ALOX15 RC3H2 MIA3 MYOT DSC3 DOCK8 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 ARG2 CELSR1 HMCN1 TLN1 LRP6 MDGA1 TNXB CDH10 CDH15	3.14e-07	1077	285	37	GO:0098609
GeneOntologyBiologicalProcess	arginine catabolic process	NOS1 NOS2 NOS3 ARG2	7.02e-06	10	285	4	GO:0006527
GeneOntologyBiologicalProcess	positive regulation of guanylate cyclase activity	NOS1 NOS2 NOS3	5.06e-05	6	285	3	GO:0031284
GeneOntologyBiologicalProcess	cell morphogenesis	EPHB2 RIPOR2 RAPH1 MYCBP2 ADGRB1 CDH23 TENM2 ADCY1 FZD4 TAOK3 FAT1 SLITRK2 DST MYO3B CGN PKHD1 OLFM1 CPNE1 VHL COL6A1 SEMA4B ABI1 MYOT FAT3 LAMA5 RTN4RL1 XK CDH19 CNTNAP2 PLXNA4 LRP6 CDH10 CUX1 CDH15	5.21e-05	1194	285	34	GO:0000902
GeneOntologyBiologicalProcess	regulation of establishment or maintenance of cell polarity	RIPOR2 DOCK8 ARFGEF1 RICTOR LLGL2	5.22e-05	30	285	5	GO:0032878
GeneOntologyBiologicalProcess	neuron projection development	EPHB2 RIPOR2 RAPH1 MYCBP2 INPPL1 ADGRB1 CDH23 TENM2 ADCY1 TWF1 FZD4 TAOK3 SLITRK2 DST MYO3B OLFM1 CPNE1 SEMA4B ABI1 MYOT GPR37 FAT3 ARFGEF1 LAMA5 RTN4RL1 DDX56 XK EFHC2 CSPG4 CNTNAP2 PLXNA4 LRP6 SAMD14 TNXB CUX1	9.75e-05	1285	285	35	GO:0031175
GeneOntologyBiologicalProcess	positive regulation of nucleotide metabolic process	ZBTB20 RPTOR NOS1 NOS2 NOS3 VCP	1.08e-04	55	285	6	GO:0045981
GeneOntologyBiologicalProcess	positive regulation of purine nucleotide metabolic process	ZBTB20 RPTOR NOS1 NOS2 NOS3 VCP	1.08e-04	55	285	6	GO:1900544
GeneOntologyBiologicalProcess	regulation of filopodium assembly	EPHB2 RIPOR2 DOCK11 TRPM2 TENM2 MYO3B	1.33e-04	57	285	6	GO:0051489
GeneOntologyBiologicalProcess	regulation of guanylate cyclase activity	NOS1 NOS2 NOS3	1.39e-04	8	285	3	GO:0031282
GeneOntologyBiologicalProcess	arginine metabolic process	NOS1 NOS2 NOS3 ARG2	1.45e-04	20	285	4	GO:0006525
GeneOntologyBiologicalProcess	regulation of purine nucleotide metabolic process	ZBTB20 RPTOR JMJD8 NOS1 NOS2 NOS3 VCP MACROH2A1	1.66e-04	112	285	8	GO:1900542
GeneOntologyBiologicalProcess	regulation of nucleotide metabolic process	ZBTB20 RPTOR JMJD8 NOS1 NOS2 NOS3 VCP MACROH2A1	1.76e-04	113	285	8	GO:0006140
GeneOntologyCellularComponent	cell-cell junction	EPPK1 CADM4 TRPC4 ADGRB1 OBSCN TENM2 TWF1 FZD4 FAT1 DST CGN NECTIN4 TLN2 WNK3 MPP3 DSC3 CDH19 LLGL2 HMCN1 TLN1 CNTNAP2 CDH10 CDH15	7.08e-06	591	285	23	GO:0005911
GeneOntologyCellularComponent	filopodium	RIPOR2 RAPH1 INPPL1 ITGAV TENM2 TWF1 FAT1 MYO3B DYNC1H1 ABI1	7.33e-06	123	285	10	GO:0030175
GeneOntologyCellularComponent	anchoring junction	EPPK1 CADM4 TRPC4 ADGRB1 OBSCN ITGAV TENM2 TWF1 FZD4 FAT1 DST CGN NECTIN4 TLN2 BCAR3 MAPRE2 WNK3 MPP3 DSC3 ASAP3 GRB7 CDH19 LLGL2 HMCN1 TLN1 CSPG4 CNTNAP2 CDH10 CDH15	7.34e-05	976	285	29	GO:0070161
GeneOntologyCellularComponent	actin-based cell projection	RIPOR2 RAPH1 MYO7B INPPL1 CDH23 CDHR5 ITGAV TENM2 TWF1 FAT1 MYO3B DYNC1H1 ABI1	1.23e-04	278	285	13	GO:0098858
GeneOntologyCellularComponent	lamellipodium membrane	PIEZO1 ITGAV DOCK8 CSPG4	2.04e-04	22	285	4	GO:0031258
GeneOntologyCellularComponent	cluster of actin-based cell projections	RIPOR2 MYO7B CDH23 CDHR5 MYO3B CGN CA4 MYO18A SLC5A2 SLCO1A2 ENPEP	2.58e-04	223	285	11	GO:0098862
GeneOntologyCellularComponent	sarcolemma	OBSCN DST FER1L5 NOS1 NOS3 CA4 COL6A1 COL6A2 COL6A3 MYOT	2.92e-04	190	285	10	GO:0042383
GeneOntologyCellularComponent	cell projection membrane	RIPOR2 PDE6B PIEZO1 CDHR5 ITGAV TWF1 PKD1 CA4 DOCK8 SLC5A2 SLCO1A2 TLN1 CSPG4 CNTNAP2 SNTG1 ENPEP	3.05e-04	431	285	16	GO:0031253
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	SMG1 PATL2 RC3H1 RPTOR VCP RC3H2 GRB7 KHSRP AGO1 HELZ2 OGFOD1 PPP6R2	3.44e-04	269	285	12	GO:0036464
GeneOntologyCellularComponent	cytoplasmic stress granule	RC3H1 RPTOR VCP RC3H2 GRB7 KHSRP OGFOD1	3.45e-04	96	285	7	GO:0010494
GeneOntologyCellularComponent	collagen-containing extracellular matrix	F13A1 FREM2 DST C1QC COL6A1 COL6A2 COL6A3 COL6A6 LAMA5 ITIH5 ADAMTS10 MST1 TGM3 EYS HMCN1 CSPG4 BCAM TNXB	3.81e-04	530	285	18	GO:0062023
GeneOntologyCellularComponent	proteasome regulatory particle, base subcomplex	PSMC4 PSMD1 PSMD4	5.04e-04	12	285	3	GO:0008540
GeneOntologyCellularComponent	apical part of cell	RIPOR2 MYO7B CDH23 CDHR5 C2CD2L FAT1 SLC9B2 PKHD1 NOS3 CA4 NLRP5 MPP3 REN SLC5A2 SLCO1A2 CSPG4 PLET1 SLC47A1 ENPEP	5.28e-04	592	285	19	GO:0045177
GeneOntologyCellularComponent	cell leading edge	RIPOR2 RAPH1 CADM4 INPPL1 PIEZO1 ITGAV TWF1 FAT1 DST TLN2 ABI1 DOCK8 ASAP3 TLN1 CSPG4 CNTNAP2 SNTG1	5.45e-04	500	285	17	GO:0031252
GeneOntologyCellularComponent	TAP complex	TAP1 TAP2	5.51e-04	3	285	2	GO:0042825
GeneOntologyCellularComponent	collagen type VI trimer	COL6A1 COL6A3	5.51e-04	3	285	2	GO:0005589
GeneOntologyCellularComponent	collagen beaded filament	COL6A1 COL6A3	5.51e-04	3	285	2	GO:0098647
GeneOntologyCellularComponent	extrinsic component of plasma membrane	CDH23 TENM2 OLFM1 C1QC CDH19 TGM3 CDH10 CDH15	5.93e-04	137	285	8	GO:0019897
GeneOntologyCellularComponent	ribonucleoprotein granule	SMG1 PATL2 RC3H1 RPTOR VCP RC3H2 GRB7 KHSRP AGO1 HELZ2 OGFOD1 PPP6R2	6.12e-04	287	285	12	GO:0035770
GeneOntologyCellularComponent	extracellular matrix	F13A1 FREM2 FCGBP DST C1QC COL6A1 COL6A2 COL6A3 COL6A6 LAMA5 RTN4RL1 ITIH5 ADAMTS10 MST1 TGM3 EYS HMCN1 CSPG4 BCAM TNXB	7.19e-04	656	285	20	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	F13A1 FREM2 FCGBP DST C1QC COL6A1 COL6A2 COL6A3 COL6A6 LAMA5 RTN4RL1 ITIH5 ADAMTS10 MST1 TGM3 EYS HMCN1 CSPG4 BCAM TNXB	7.47e-04	658	285	20	GO:0030312
GeneOntologyCellularComponent	catenin complex	CDH23 CDH19 CDH10 CDH15	9.00e-04	32	285	4	GO:0016342
GeneOntologyCellularComponent	brush border	MYO7B CDHR5 CGN CA4 MYO18A SLC5A2 SLCO1A2 ENPEP	1.17e-03	152	285	8	GO:0005903
GeneOntologyCellularComponent	myosin complex	MYH13 MYO7B MYO3B CGN MYO18A	1.25e-03	59	285	5	GO:0016459
GeneOntologyCellularComponent	proteasome complex	PSMC4 PSMD1 PSMD4 VCP ECPAS	2.20e-03	67	285	5	GO:0000502
HumanPheno	Curved toe phalanx	COL6A1 COL6A2 COL6A3	3.17e-05	4	103	3	HP:0010176
HumanPheno	Reduced muscle collagen VI	COL6A1 COL6A2 COL6A3	3.17e-05	4	103	3	HP:0030095
HumanPheno	Reduced maximal expiratory pressure	COL6A1 COL6A2 COL6A3	3.17e-05	4	103	3	HP:0012497
Domain	CA	CDH23 CDHR5 FREM2 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	2.02e-09	115	281	14	SM00112
Domain	Cadherin	CDH23 CDHR5 FREM2 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	2.84e-09	118	281	14	IPR002126
Domain	Cadherin_CS	CDH23 CDHR5 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	9.90e-09	109	281	13	IPR020894
Domain	ARM-type_fold	CEP104 RALGAPA1 SMG1 TRPC4AP RIPOR2 DOCK11 PSMD1 ITPR2 TELO2 PIK3C2B RPTOR HEATR5B DOCK8 ARFGEF1 RICTOR IPO4 ECPAS IPO9 USO1 PPP6R2 STAG3 IPO11	1.01e-08	339	281	22	IPR016024
Domain	CADHERIN_1	CDH23 CDHR5 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	1.54e-08	113	281	13	PS00232
Domain	-	CDH23 CDHR5 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	1.72e-08	114	281	13	2.60.40.60
Domain	CADHERIN_2	CDH23 CDHR5 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	1.72e-08	114	281	13	PS50268
Domain	Cadherin-like	CDH23 CDHR5 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	2.12e-08	116	281	13	IPR015919
Domain	Cadherin	CDH23 FAT1 PCDH10 DSC3 PCDHGA7 PCDHGA6 FAT3 PCDHB6 CDH19 CELSR1 CDH10 CDH15	1.36e-07	113	281	12	PF00028
Domain	VWFA	PSMD4 ITGAD CPNE1 COL6A1 COL6A2 COL6A3 COL6A6 CACHD1 ITIH5 HMCN1	4.17e-07	82	281	10	PS50234
Domain	VWA	PSMD4 ITGAD CPNE1 COL6A1 COL6A2 COL6A3 COL6A6 CACHD1 ITIH5 HMCN1	5.25e-07	84	281	10	SM00327
Domain	FAD_binding_1	NDOR1 NOS1 NOS2 NOS3	7.35e-07	6	281	4	PF00667
Domain	FAD-binding_1	NDOR1 NOS1 NOS2 NOS3	7.35e-07	6	281	4	IPR003097
Domain	NADPH_Cyt_P450_Rdtase_dom3	NDOR1 NOS1 NOS2 NOS3	7.35e-07	6	281	4	IPR023173
Domain	-	NDOR1 NOS1 NOS2 NOS3	7.35e-07	6	281	4	1.20.990.10
Domain	LAM_G_DOMAIN	FAT1 FAT3 LAMA5 EYS CELSR1 CSPG4 CNTNAP2	1.37e-06	38	281	7	PS50025
Domain	Laminin_G_2	FAT1 FAT3 LAMA5 EYS CELSR1 CSPG4 CNTNAP2	1.97e-06	40	281	7	PF02210
Domain	VWF_A	PSMD4 ITGAD CPNE1 COL6A1 COL6A2 COL6A3 COL6A6 CACHD1 ITIH5 HMCN1	2.43e-06	99	281	10	IPR002035
Domain	Flavdoxin-like	NDOR1 NOS1 NOS2 NOS3	3.35e-06	8	281	4	IPR001094
Domain	FLAVODOXIN_LIKE	NDOR1 NOS1 NOS2 NOS3	3.35e-06	8	281	4	PS50902
Domain	Flavodoxin_1	NDOR1 NOS1 NOS2 NOS3	3.35e-06	8	281	4	PF00258
Domain	Flavodoxin/NO_synth	NDOR1 NOS1 NOS2 NOS3	3.35e-06	8	281	4	IPR008254
Domain	NO_synthase	NOS1 NOS2 NOS3	3.37e-06	3	281	3	PF02898
Domain	NOS_euk	NOS1 NOS2 NOS3	3.37e-06	3	281	3	IPR012144
Domain	NOS_N	NOS1 NOS2 NOS3	3.37e-06	3	281	3	IPR004030
Domain	-	NOS1 NOS2 NOS3	3.37e-06	3	281	3	3.90.340.10
Domain	NOS	NOS1 NOS2 NOS3	3.37e-06	3	281	3	PS60001
Domain	ARM-like	CEP104 SMG1 RIPOR2 PSMD1 TELO2 RPTOR HEATR5B DOCK8 ARFGEF1 RICTOR IPO4 ECPAS IPO9 PPP6R2 STAG3 IPO11	3.57e-06	270	281	16	IPR011989
Domain	LamG	FAT1 FAT3 LAMA5 EYS CELSR1 CSPG4 CNTNAP2	3.85e-06	44	281	7	SM00282
Domain	Flavoprot_Pyr_Nucl_cyt_Rdtase	NDOR1 NOS1 NOS2 NOS3	9.81e-06	10	281	4	IPR001709
Domain	-	NDOR1 NOS1 NOS2 NOS3	9.81e-06	10	281	4	3.40.50.360
Domain	Flavoprotein-like_dom	NDOR1 NOS1 NOS2 NOS3	9.81e-06	10	281	4	IPR029039
Domain	AAA+_ATPase	ABCA4 ABCA13 PSMC4 TAP1 TAP2 DYNC1H1 VCP DNAH10 RNF213 RFC2 HELZ2	1.17e-05	144	281	11	IPR003593
Domain	AAA	ABCA4 ABCA13 PSMC4 TAP1 TAP2 DYNC1H1 VCP DNAH10 RNF213 RFC2 HELZ2	1.17e-05	144	281	11	SM00382
Domain	-	PSMD4 COL6A1 COL6A2 COL6A3 COL6A6 CACHD1 ITIH5 HMCN1	1.52e-05	74	281	8	3.40.50.410
Domain	VWA	ITGAD COL6A1 COL6A2 COL6A3 COL6A6 CACHD1 ITIH5	2.00e-05	56	281	7	PF00092
Domain	OxRdtase_FAD/NAD-bd	NDOR1 NOS1 NOS2 NOS3	2.26e-05	12	281	4	IPR001433
Domain	NAD_binding_1	NDOR1 NOS1 NOS2 NOS3	2.26e-05	12	281	4	PF00175
Domain	Laminin_G	FAT1 FAT3 LAMA5 EYS CELSR1 CSPG4 CNTNAP2	2.53e-05	58	281	7	IPR001791
Domain	-	CEP104 RIPOR2 PSMD1 TELO2 RPTOR HEATR5B ARFGEF1 RICTOR IPO4 ECPAS IPO9 STAG3 IPO11	3.34e-05	222	281	13	1.25.10.10
Domain	EGF	BRINP3 TENM2 FAT1 FCGBP FAT3 LAMA5 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	6.01e-05	235	281	13	SM00181
Domain	DUF3398	DOCK11 DOCK6 DOCK8	6.52e-05	6	281	3	PF11878
Domain	DOCK_C/D_N	DOCK11 DOCK6 DOCK8	6.52e-05	6	281	3	IPR021816
Domain	P-loop_NTPase	ABCA4 MYH13 MYO7B ABCA13 PSMC4 GUF1 MYO3B CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP NLRP5 MPP3 NWD1 KIF27 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10 HYDIN	8.55e-05	848	281	28	IPR027417
Domain	EGF-like_dom	TENM2 FAT1 FCGBP C6 FAT3 LAMA5 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	1.08e-04	249	281	13	IPR000742
Domain	TRPC_channel	TRPC4 TRPM2 TRPC7	1.13e-04	7	281	3	IPR002153
Domain	FAD_FR	NDOR1 NOS1 NOS2 NOS3	1.63e-04	19	281	4	PS51384
Domain	Fd_Rdtase_FAD-bd	NDOR1 NOS1 NOS2 NOS3	1.63e-04	19	281	4	IPR017927
Domain	Riboflavin_synthase-like_b-brl	NDOR1 NOS1 NOS2 NOS3	1.63e-04	19	281	4	IPR017938
Domain	EGF_2	EPHB2 TENM2 FAT1 C6 FAT3 LAMA5 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	2.00e-04	265	281	13	PS01186
Domain	-	TLN2 TLN1	2.26e-04	2	281	2	1.20.1420.10
Domain	VBS	TLN2 TLN1	2.26e-04	2	281	2	PF08913
Domain	Talin_cent	TLN2 TLN1	2.26e-04	2	281	2	IPR015224
Domain	EIF3C_N_dom	EIF3CL EIF3C	2.26e-04	2	281	2	IPR008905
Domain	eIF-3c_N	EIF3CL EIF3C	2.26e-04	2	281	2	PF05470
Domain	Tap1/ABCB2	TAP1 TAP2	2.26e-04	2	281	2	IPR013306
Domain	ABC_Tap-like	TAP1 TAP2	2.26e-04	2	281	2	IPR013305
Domain	Talin_middle	TLN2 TLN1	2.26e-04	2	281	2	PF09141
Domain	Tap2/ABCB3	TAP1 TAP2	2.26e-04	2	281	2	IPR005293
Domain	EIF3C	EIF3CL EIF3C	2.26e-04	2	281	2	IPR027516
Domain	Vinculin-bd_dom	TLN2 TLN1	2.26e-04	2	281	2	IPR015009
Domain	-	ABCA4 MYO7B ABCA13 PSMC4 GUF1 CHD6 DNM1 TAP1 TAP2 DYNC1H1 VCP MPP3 NWD1 DNAH10 MYO18A RNF213 DDX56 DDX51 RFC2 GTPBP1 ARL4D HELZ2 SEPTIN10 HYDIN	4.04e-04	746	281	24	3.40.50.300
Domain	Cadherin_C	DSC3 CDH19 CDH10 CDH15	4.94e-04	25	281	4	PF01049
Domain	Cadherin_cytoplasmic-dom	DSC3 CDH19 CDH10 CDH15	4.94e-04	25	281	4	IPR000233
Domain	EGF_1	TENM2 FAT1 C6 FAT3 LAMA5 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	5.07e-04	255	281	12	PS00022
Domain	DOCK	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	IPR026791
Domain	DOCK_C	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	IPR010703
Domain	DOCK-C2	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	PF14429
Domain	DHR-1_domain	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	IPR027007
Domain	DHR_2	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	PS51651
Domain	DHR_1	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	PS51650
Domain	DHR-2	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	PF06920
Domain	DHR-2	DOCK11 DOCK6 DOCK8	5.08e-04	11	281	3	IPR027357
Domain	-	FAT1 FAT3 LAMA5 EYS CELSR1 CSPG4 CNTNAP2	5.79e-04	95	281	7	2.60.120.200
Domain	EGF-like_CS	TENM2 FAT1 C6 FAT3 LAMA5 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	6.23e-04	261	281	12	IPR013032
Domain	HEAT_REPEAT	CEP104 SMG1 HEATR5B IPO4 ECPAS IPO11	6.44e-04	70	281	6	PS50077
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML3	6.70e-04	3	281	2	IPR019082
Domain	MamL-1	MAML1 MAML3	6.70e-04	3	281	2	PF09596
Domain	MamL-1	MAML1 MAML3	6.70e-04	3	281	2	SM01275
Domain	Talin-1	TLN2 TLN1	6.70e-04	3	281	2	IPR015710
Domain	Catenin_binding_dom	DSC3 CDH19 CDH10 CDH15	8.86e-04	29	281	4	IPR027397
Domain	-	DSC3 CDH19 CDH10 CDH15	8.86e-04	29	281	4	4.10.900.10
Domain	EGF_3	TENM2 FAT1 C6 FAT3 ADAM32 EYS CELSR1 HMCN1 CNTNAP2 LRP6 TNXB	9.00e-04	235	281	11	PS50026
Domain	IMPORTIN_B_NT	IPO4 IPO9 IPO11	1.08e-03	14	281	3	PS50166
Domain	FERM_f0	TLN2 TLN1	1.33e-03	4	281	2	PF16511
Domain	ILWEQ	TLN2 TLN1	1.33e-03	4	281	2	PD011820
Domain	I_LWEQ	TLN2 TLN1	1.33e-03	4	281	2	PF01608
Domain	I_LWEQ	TLN2 TLN1	1.33e-03	4	281	2	PS50945
Domain	FERM_f0	TLN2 TLN1	1.33e-03	4	281	2	IPR032425
Domain	ILWEQ_dom	TLN2 TLN1	1.33e-03	4	281	2	IPR002558
Domain	ILWEQ	TLN2 TLN1	1.33e-03	4	281	2	SM00307
Domain	-	TLN2 TLN1	1.33e-03	4	281	2	1.20.1410.10
Domain	IBN_N	IPO4 IPO9 IPO11	1.34e-03	15	281	3	PF03810
Domain	IBN_N	IPO4 IPO9 IPO11	1.63e-03	16	281	3	SM00913
Domain	Ion_trans_dom	TRPC4 TRPM2 ITPR2 KCNU1 KCNQ5 TRPC7 KCNH5	1.69e-03	114	281	7	IPR005821
Domain	Ion_trans	TRPC4 TRPM2 ITPR2 KCNU1 KCNQ5 TRPC7 KCNH5	1.69e-03	114	281	7	PF00520
Domain	HEAT	CEP104 RPTOR IPO4 ECPAS IPO11	1.78e-03	58	281	5	IPR000357
Domain	Importin-beta_N	IPO4 IPO9 IPO11	1.96e-03	17	281	3	IPR001494
Domain	Myosin_tail_1	MYH13 CGN MYO18A	2.33e-03	18	281	3	PF01576
Domain	Myosin_tail	MYH13 CGN MYO18A	2.33e-03	18	281	3	IPR002928
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPIRE2 NDOR1 EPPK1 MYCBP2 INPPL1 PIEZO1 OBSCN MAML1 EXTL3 ITPR2 C2CD2L SCAF1 FAT1 SLC38A10 DST PIK3C2B RPTOR BANP PKD1 SEC16A TLN2 DOCK6 DYNC1H1 MPP3 SEMA4B HECTD4 LAMA5 DDX56 SMG5 CELSR1 LLGL2 TTLL4 PPP1R15B TLN1 CSPG4 HELZ2 ZFYVE26 BCAM ANKRD33B CYTH4	4.85e-15	1105	287	40	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CEP104 RALGAPA1 SMG1 PIEZO1 MAML1 UBXN4 DST TELO2 FDPS RPTOR CPNE1 DOCK6 USP28 HECTD4 LAMA5 SMG5 CACHD1 SIK3 ECPAS TRIM9 TTLL4 CNTNAP2	7.33e-10	529	287	22	14621295
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PRPSAP2 MYCBP2 ADGRB1 PSMC4 PSMD1 PSMD4 TENM2 EIF3CL C2CD2L UBXN4 KCNQ5 FDPS RPTOR OLFM1 TLN2 MAPRE2 NOS1 VCP MIA3 ABI1 CAD MYO18A RICTOR MACROH2A1 RBM39 PDXK KHSRP TRIM9 CNTNAP2 EIF3C SEPTIN10 PPP6R2	1.92e-09	1139	287	32	36417873
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	TRPC4 FREM2 COL6A1 COL6A2 COL6A3 CSPG4	2.24e-09	16	287	6	16880404
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	EPPK1 ABCA13 PSMC4 RPTOR CGN PKHD1 C1QC TLN2 DNM1 VCP NLRP5 MYO18A RNF213 TLN1	2.47e-09	208	287	14	33230847
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ILF2 DOCK11 ADGRB1 OBSCN ITPR2 SCAF1 FREM2 SLC38A10 DST MYO3B PKD1 PKHD1 CHD6 C6 PCDH10 DYNC1H1 DSE GPR37 RNF213 ECPAS SLC5A2 MST1 TRIM9 TLN1 PLXNA4	3.12e-09	736	287	25	29676528
Pubmed	Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen.	COL6A1 COL6A2 COL6A3 TNXB	4.54e-09	4	287	4	15194424
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	CDHR5 F13A1 FREM2 FCGBP OLFM1 C6 SEMA4B COL6A3 APMAP MST1 CSPG4 BCAM MDGA1 TNXB ENPEP	4.64e-09	257	287	15	16335952
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	EPPK1 MYH13 PSMC4 PSMD1 PSMD4 AARS2 SEC16A CPNE1 PRPF39 MVP TAP2 DYNC1H1 VCP CAD APMAP MYO18A LAMA5 RFC2 IPO4 PDXK KHSRP TGM3 IPO9	5.88e-09	647	287	23	26618866
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PSMC4 PSMD1 XAB2 UBXN4 CEP120 AARS2 TELO2 RPTOR ANAPC5 DYNC1H1 ABI1 APMAP POLR2B DDX56 DDX51 RFC2 IPO4 ECPAS IPO9 USO1 IPO11	1.10e-08	560	287	21	35241646
Pubmed	Genetic variations in nitric oxide synthase and arginase influence exhaled nitric oxide levels in children.	NOS1 NOS2 NOS3 ARG2	2.26e-08	5	287	4	21039601
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A1 COL6A2 COL6A3 COL6A6	2.26e-08	5	287	4	23869615
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 XAB2 FREM2 TAOK3 DST BUB1 MLH1 DNM1 ANAPC5 COL6A2 RC3H2 MIA3 RALGAPB GRB7 RICTOR SIK3 GTPBP1 MAP3K6 LLGL2 OGFOD1 SLC12A7 PPP6R2	3.04e-08	650	287	22	38777146
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DPF1 ILF2 MYCBP2 XAB2 PPIG DST FEN1 CPNE1 CHD6 DNM1 DOCK6 MVP DYNC1H1 VCP CAD APMAP POLR2B HECTD4 MYO18A DDX56 MACROH2A1 SIK3 RBM39 KHSRP AGO1 KCTD3 HELZ2 EIF3C TNXB	3.20e-08	1082	287	29	38697112
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ILF2 MYCBP2 DOCK11 TRPC4 TENM2 TWF1 DST RPTOR SEC16A TLN2 DNM1 NOS1 DYNC1H1 WNK3 MIA3 ABI1 CAD USP28 HECTD4 MACROH2A1 SIK3 IPO4 KHSRP AGO1 PPP6R2 CDH10 CUX1	3.96e-08	963	287	27	28671696
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	EPHB2 EPPK1 PSMC4 PSMD4 TTC1 XAB2 TWF1 UBXN4 FCGBP AARS2 FEN1 SEC16A CPNE1 MVP VCP DSC3 APMAP MYO18A ARFGEF1 RNF213 MACROH2A1 RFC2 IPO4 GTPBP1 ECPAS RBM39 KHSRP TGM3 IPO9 USO1 TLN1 EIF3C IPO11	4.10e-08	1367	287	33	32687490
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	EPPK1 ILF2 MYCBP2 PSMC4 PSMD1 TELO2 CGN SEC16A DYNC1H1 HECTD4 MYO18A RNF213 MACROH2A1 IPO4	5.07e-08	264	287	14	32814769
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 MYCBP2 C2CD2L DST SEC16A TLN2 CHD6 RALGAPB SMG5 SIK3 TRIM9 TLN1 HELZ2	5.65e-08	225	287	13	12168954
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PSMC4 PSMD1 AARS2 TELO2 COG1 RPTOR FEN1 RFT1 HEATR5B MAPRE2 ANAPC5 DYNC1H1 WNK3 VCP MIA3 POLR2B ARFGEF1 CACHD1 IPO4 ECPAS IPO9 USO1 TLN1 LRP6 SLC47A1 IPO11	9.72e-08	942	287	26	31073040
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ILF2 KIAA0586 PSMC4 PSMD1 PSMD4 EIF3CL SCAF1 RPTOR FEN1 TLN2 DYNC1H1 MGAM2 CAD KIF27 DNAH10 APMAP POLR2B DDX56 MACROH2A1 RFC2 IPO4 GTPBP1 ECPAS RBM39 PDXK KHSRP SLC5A2 TGM3 IPO9 USO1 TLN1 ZC3HAV1L EIF3C	1.07e-07	1425	287	33	30948266
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	SMG1 PSMC4 PSMD1 PSMD4 EXTL3 TWF1 ITPR2 DST AARS2 TELO2 COG1 FDPS TAP1 TAP2 DYNC1H1 VCP CAD POLR2B RNF213 DDX56 RFC2 IPO4 ECPAS IFIT3 RBM39 PDXK KHSRP ARG2 IPO9 TLN1 EIF3C CUX1 IPO11	1.37e-07	1440	287	33	30833792
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 ILF2 MYCBP2 PSMD1 XAB2 DST CGN SEC16A MVP DYNC1H1 VCP CAD DDX56 DDX51 IPO4 ECPAS RBM39 KHSRP TGM3 TLN1 HELZ2	1.48e-07	653	287	21	22586326
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A1 COL6A2 COL6A3 COL6A6	1.56e-07	7	287	4	18400749
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A1 COL6A2 COL6A3 COL6A6	1.56e-07	7	287	4	18276594
Pubmed	Defining the membrane proteome of NK cells.	ILF2 MYCBP2 PSMC4 PSMD1 XAB2 ITPR2 BUB1 FEN1 MLH1 HEATR5B MVP TAP1 TAP2 DYNC1H1 MIA3 CAD DOCK8 APMAP MYO18A RNF213 DDX56 DDX51 IPO4 GTPBP1 ECPAS KHSRP IPO9 USO1 HELZ2	1.61e-07	1168	287	29	19946888
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	F13A1 C1QC COL6A1 COL6A2 COL6A3 COL6A6 LAMA5 ITIH5 CSPG4 TNXB	1.99e-07	135	287	10	28675934
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 RAPH1 MYCBP2 PSMC4 PSMD1 PSMD4 ITPR2 UBXN4 TELO2 CGN SEC16A MLH1 MAPRE2 MIA3 CAD DSC3 POLR2B RALGAPB RNF213 RICTOR CACHD1 IPO9 KCTD3 LRP6 EIF3C SLC12A7 PPP6R2	2.19e-07	1049	287	27	27880917
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 SPIRE2 AFTPH RAPH1 MYCBP2 DOCK11 INPPL1 TWF1 DST KCNQ5 PIK3C2B RPTOR CGN SEC16A DOCK6 WNK3 ABI1 RALGAPB RICTOR SIK3 MAP3K6 IPO9 USO1 TRIM9	2.59e-07	861	287	24	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 CPAMD8 TRPC4AP ZBTB20 MYCBP2 INPP4A TRPM2 OBSCN PSMD1 ADCY1 INKA2 MALT1 KCNQ5 RPTOR ZNF589 BANP CHD6 DOCK6 MAML3 MIA3 MAN2B2 APMAP RALGAPB HECTD4 RNF213 RTN4RL1 DDX56 MACROH2A1 ECPAS RBM39 PDXK CUX1 CDH15	2.91e-07	1489	287	33	28611215
Pubmed	Genetic polymorphisms associated with priapism in sickle cell disease.	ITGAV F13A1 NOS2 NOS3	3.10e-07	8	287	4	17408468
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	COL6A1 COL6A2 COL6A3 LAMA5	3.10e-07	8	287	4	12766770
Pubmed	A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.	COL6A1 COL6A3 COL6A6 TNXB	3.10e-07	8	287	4	24563484
Pubmed	Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan.	INPPL1 MALT1 GUF1 SLC38A10 TELO2 DOCK6 PRPF39 HECTD4 ARFGEF1 RICTOR LLGL2	4.05e-07	183	287	11	31932471
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	SUPT20HL1 DOCK11 SUPT20HL2 DST NFE2 FEN1 CHD6 NOS2 COL6A2 COL6A3 POLR2B HECTD4 LAMA5 PPARG SCMH1	4.28e-07	363	287	15	14691545
Pubmed	Paradoxical roles of different nitric oxide synthase isoforms in colonic injury.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	14665440
Pubmed	Deletion of neuronal NOS prevents impaired vasodilation in septic mouse skeletal muscle.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	17258180
Pubmed	Amino acid sequence of the triple-helical domain of human collagen type VI.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	3198591
Pubmed	Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	8489506
Pubmed	Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	18366090
Pubmed	Collagen VI related muscle disorders.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	16141002
Pubmed	Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	15180967
Pubmed	Collagen VI-Related Dystrophies	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	20301676
Pubmed	Decreased viability of nitric oxide synthase double knockout mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	12704728
Pubmed	Molecular and biochemical characterization of nitric oxide synthase isoforms and their intracellular distribution in human peripheral blood mononuclear cells.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	21722677
Pubmed	Nitric oxide is proangiogenic in the retina and choroid.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	11920687
Pubmed	Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10330441
Pubmed	Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	17395508
Pubmed	Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	8943206
Pubmed	Reduced spinal microglial activation and neuropathic pain after nerve injury in mice lacking all three nitric oxide synthases.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	21756313
Pubmed	Nitric oxide synthase expression and role during cardiomyogenesis.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10690339
Pubmed	Molecular control of nitric oxide synthases in the cardiovascular system.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10690323
Pubmed	Collagen type VI myopathies.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	24443028
Pubmed	Expression of nitric oxide synthases in leukocytes in nasal polyps.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	22374200
Pubmed	Nitric oxide synthases: three pieces to the puzzle?	NOS1 NOS2 NOS3	5.56e-07	3	287	3	25366612
Pubmed	Genetic Models in Applied Physiology. Differential role of nitric oxide synthase isoforms in fever of different etiologies: studies using Nos gene-deficient mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	12562678
Pubmed	Expression of type VI collagen in the developing mouse heart.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	9520112
Pubmed	Nitric oxide synthase isoforms play distinct roles during acute peritonitis.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	19706695
Pubmed	Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	3348212
Pubmed	Molecular architecture of mammalian nitric oxide synthases.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	25125509
Pubmed	Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10484454
Pubmed	Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	9870939
Pubmed	Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	20304785
Pubmed	Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	21459131
Pubmed	Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	36982625
Pubmed	Nitric oxide synthases: which, where, how, and why?	NOS1 NOS2 NOS3	5.56e-07	3	287	3	9410890
Pubmed	Cellular and molecular mechanisms of endothelial cell dysfunction.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	9410891
Pubmed	Nitric oxide synthase gene polymorphisms in functional dyspepsia.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	24114042
Pubmed	Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10516139
Pubmed	Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10362674
Pubmed	Defective fluid and HCO(3)(-) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10966931
Pubmed	Permissive role of nitric oxide in macula densa control of renin secretion.	NOS1 NOS3 REN	5.56e-07	3	287	3	15075180
Pubmed	Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	25017185
Pubmed	Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 expression is NOS3 dependent.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	20953358
Pubmed	Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	20581102
Pubmed	Expression profiles of NOS isoforms in gingiva of nNOS knockout mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	24657074
Pubmed	Vascular biology in genetically altered mice : smaller vessels, bigger insight.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10590250
Pubmed	2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	35772285
Pubmed	Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	24305053
Pubmed	Lessons learned from nitric oxide synthase knockout animals.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10709868
Pubmed	Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	25813085
Pubmed	Expression of collagen alpha 1(VI), alpha 2(VI), and alpha 3(VI) chains in the pregnant mouse uterus.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	7780011
Pubmed	Limb reduction defects in endothelial nitric oxide synthase-deficient mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	9843834
Pubmed	Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	9843821
Pubmed	High-protein-induced glomerular hyperfiltration is independent of the tubuloglomerular feedback mechanism and nitric oxide synthases.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	20739607
Pubmed	Expression of nitric oxide synthase isoforms in human pregnant myometrium at term.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	12445599
Pubmed	Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.	TRPC4AP TAP1 TAP2	5.56e-07	3	287	3	11133832
Pubmed	Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10203575
Pubmed	Analysis of nitric oxide synthase genes in cluster headache.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	12421162
Pubmed	Partial cloning of constitutive and inducible nitric oxide synthases and detailed neuronal expression of NOS mRNA in the cerebellum and optic tectum of adult Atlantic salmon (Salmo salar).	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10891583
Pubmed	Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	15217783
Pubmed	Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing.	TRPC4AP TAP1 TAP2	5.56e-07	3	287	3	11532960
Pubmed	Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10068656
Pubmed	Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.	COL6A1 COL6A2 COL6A3	5.56e-07	3	287	3	25204870
Pubmed	Crucial roles of nitric oxide synthases in β-adrenoceptor-mediated bladder relaxation in mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	27784691
Pubmed	Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	11717657
Pubmed	Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	15242984
Pubmed	Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	14551061
Pubmed	Nitric oxide synthases and heart failure - lessons from genetically manipulated mice.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	23774658
Pubmed	Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	10443886
Pubmed	Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease.	NOS1 NOS2 NOS3	5.56e-07	3	287	3	24192154
Interaction	TOP3B interactions	SPIRE2 NDOR1 EPPK1 MYCBP2 INPPL1 PIEZO1 OBSCN MAML1 EXTL3 ITPR2 C2CD2L SCAF1 FAT1 SLC38A10 DST PIK3C2B RPTOR BANP PKD1 SEC16A TLN2 DOCK6 MOCS2 DYNC1H1 MPP3 SEMA4B RC3H2 CAD HECTD4 LAMA5 DDX56 MACROH2A1 SMG5 IPO4 GTPBP1 CELSR1 LLGL2 TTLL4 PPP1R15B TLN1 CSPG4 HELZ2 ZFYVE26 BCAM ANKRD33B CYTH4	1.91e-07	1470	281	46	int:TOP3B
Interaction	LOC254896 interactions	FREM2 FAT1 BANP COL6A2 FAT3 CELSR1 CSPG4	1.99e-06	43	281	7	int:LOC254896
Interaction	KCNA3 interactions	RALGAPA1 EPPK1 ILF2 ABCA13 PSMC4 PSMD1 DST RPTOR CGN SEC16A PKHD1 C1QC TLN2 DNM1 MAPRE2 DYNC1H1 VCP NLRP5 CAD DSC3 APMAP MYO18A RNF213 RICTOR CACHD1 ECPAS USO1 TLN1 ZC3HAV1L LRP6	5.07e-06	871	281	30	int:KCNA3
Interaction	NCR3 interactions	ITGAV COL6A1 COL6A2 SEMA4B MIA3 MAN2B2 LAMA5 CD247 CSPG4 LRP6	7.13e-06	120	281	10	int:NCR3
Interaction	RYK interactions	EPHB2 FREM2 DST PCDH10 DYNC1H1 ABI1 DSC3 PCDHGA7 PCDHGA6 FAT3 CELSR1 CSPG4 BCAM	9.32e-06	212	281	13	int:RYK
Interaction	PRG2 interactions	TRPC4AP EXTL3 ITGAV JMJD8 ZNF589 COL6A1 COL6A2 SEMA4B MIA3 MAN2B2 LAMA5 CELSR1 CSPG4 LRP6 PPP6R2	1.22e-05	285	281	15	int:PRG2
Interaction	C1orf54 interactions	BRINP3 EXTL3 ITGAV SLC38A10 PKD1 DSE SEMA4B MAN2B2 LAMA5 CACHD1 CELSR1	2.35e-05	167	281	11	int:C1orf54
Interaction	RNF123 interactions	ILF2 DOCK11 ADGRB1 OBSCN LCMT2 ITPR2 SCAF1 FREM2 SLC38A10 DST MYO3B PKD1 PKHD1 CHD6 C6 PCDH10 DYNC1H1 DSE GPR37 RNF213 ECPAS MAP3K6 SLC5A2 MST1 TRIM9 TLN1 PLXNA4	3.68e-05	824	281	27	int:RNF123
Interaction	CHRNA1 interactions	EXTL3 SLC38A10 DST TAP1 TAP2 CUX1	4.63e-05	47	281	6	int:CHRNA1
GeneFamily	Cadherin related	CDH23 CDHR5 FAT1 FAT3	2.58e-05	17	191	4	24
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DPF1 RIPOR2 RAPH1 MYCBP2 INPP4A ADGRB1 TENM2 ADCY1 TAOK3 CGN OLFM1 TLN2 DNM1 MAPRE2 WNK3 MPP3 VHL MIA3 COL6A6 ARFGEF1 LAMA5 RICTOR XK SIK3 EFHC2 SLC32A1 TRIM9 CNTNAP2 PLXNA4 SNTG1 MDGA1 SAMD14 RUNDC1 CCDC17 HYDIN	1.95e-08	1106	287	35	M39071
Coexpression	GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN	SIDT1 ITPR2 DST NFE2 PKD1 DDHD2 DYNC1H1 RALGAPB RICTOR ZFYVE26 IPO11	6.19e-07	145	287	11	M359
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RALGAPA1 SP3 AFTPH MYCBP2 EIF3CL OLFM1 MAPRE2 MIA3 RICTOR MACROH2A1 RBM39 EIF3C	3.48e-06	208	287	12	MM581
Coexpression	NABA_BASEMENT_MEMBRANES	COL6A1 COL6A2 COL6A3 COL6A6 LAMA5 HMCN1	4.59e-06	40	287	6	M5887
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	RALGAPA1 ZBTB20 RAPH1 RC3H1 IL18RAP BANP CHD6 MIA3 HECTD4 LLGL2 CUX1	8.20e-06	189	287	11	M8275
Coexpression	GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN	NDOR1 SLITRK2 ANKRD61 HEATR5B NOS1 SLC27A5 FAT3 KHSRP MST1	1.15e-05	127	287	9	M441
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	RALGAPA1 SP3 AFTPH MYCBP2 OLFM1 MAPRE2 MIA3 RICTOR MACROH2A1 RBM39 EIF3C	1.84e-05	206	287	11	M2817
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP	BRINP3 PSMC4 EXTL3 FAT1 KCNQ5 TLN2 DSE SEPTIN10 HYDIN CUX1	2.48e-05	175	287	10	M8578
Coexpression	WANG_CISPLATIN_RESPONSE_AND_XPC_UP	ILF2 TELO2 FDPS ZNF589 FEN1 MLH1 DYNC1H1 PDXK MST1 CD247	3.98e-05	185	287	10	M19511
Coexpression	DESCARTES_FETAL_EYE_MICROGLIA	DOCK11 TRPM2 F13A1 ITPR2 C1QC PLD4 DOCK8 CD247 CYTH4	4.78e-05	152	287	9	M40187
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN	CADM4 PSMD4 BUB1 PKD1 BCAR3 ANAPC5 DYNC1H1 CA4 KHSRP IPO9	6.75e-05	197	287	10	M5210
Coexpression	GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	INPP4A ITPR2 TAOK3 BANP MAML3 METTL22 DSE IER2 HELZ2 CUX1	7.35e-05	199	287	10	M5357
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN	ALS2CL MYO3B CPNE1 RNF213 RTN4RL1 CPE MACROH2A1 IFIT3 RBM39 ENPEP	7.66e-05	200	287	10	M2936
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	EPHB2 DPF1 BRINP3 ZBTB20 TAOK3 FAT1 DST CHD6 PCDH10 MOCS2 MPP3 VHL FAT3 HECTD4 CPE RFX5 IFIT3 SLC5A2 TRIM9 SCMH1 CNTNAP2 SLC12A7 SAMD14 PPP6R2	3.74e-05	721	282	24	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500	RIPOR2 ZBTB20 PRND COL6A1 COL6A2 ITIH5 TNXB	4.35e-05	71	282	7	gudmap_developingGonad_P2_epididymis_500_k1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	RIPOR2 SLITRK2 DSE COL6A3 FAT3 CASQ2 ITIH5 HMCN1 ENPEP	6.13e-05	130	282	9	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2	EPHB2 DPF1 BRINP3 ZBTB20 TAOK3 FAT1 DST CHD6 PCDH10 MOCS2 MPP3 VHL FAT3 HECTD4 CPE RFX5 IFIT3 SLC5A2 TRIM9 SCMH1 CNTNAP2 SLC12A7 SAMD14 PPP6R2	6.52e-05	747	282	24	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	SP3 RIPOR2 ZBTB20 COL6A1 COL6A2 FAT3 REN RBM39 ITIH5 MTCP1	7.84e-05	166	282	10	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	RIPOR2 PIEZO1 FDPS WNK3 DSE COL6A1 COL6A3 FAT3 RNF213 RTN4RL1 CASQ2 REN ITIH5 HMCN1 ENPEP	9.06e-05	356	282	15	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2	CADM4 CGN NECTIN4 BCAR3 DOCK8 APMAP GRB7 LAMA5 RNF213 RTN4RL1 IL17RC REN CDCP1 IER2 LLGL2 PLET1 BCAM	9.28e-05	441	282	17	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5	EPHB2 DPF1 BRINP3 ZBTB20 TAOK3 FAT1 DST CHD6 PCDH10 MPP3 VHL FAT3 HECTD4 CPE RFX5 IFIT3 SLC5A2 TRIM9 SCMH1 CNTNAP2 SLC12A7 SAMD14 PPP6R2	1.05e-04	722	282	23	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	RIPOR2 PIEZO1 FAT1 WNK3 DSE COL6A1 COL6A3 FAT3 RNF213 RTN4RL1 CASQ2 REN ITIH5 HMCN1 ENPEP	1.16e-04	364	282	15	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK11 PIEZO1 F13A1 C1QC PLD4 COL6A1 COL6A2 COL6A3 CPE ITIH5 SLCO1A2 SERTAD4 PLXNA4 TNXB CYTH4	1.35e-04	369	282	15	gudmap_kidney_adult_RenalCapsule_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#3	TENM2 CGN ALOX15 GRB7 LAMA5 CDCP1 CELSR1 LLGL2 BCAM	1.35e-04	144	282	9	Facebase_RNAseq_e10.5_Olfactory Pit_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5	EPHB2 DPF1 BRINP3 ZBTB20 AFTPH TAOK3 FAT1 DST CHD6 PCDH10 MPP3 FAT3 HECTD4 CPE RFX5 IFIT3 SLC5A2 TRIM9 SCMH1 CNTNAP2 SAMD14 PPP6R2	1.41e-04	688	282	22	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	SLITRK2 COL6A3 FAT3 RTN4RL1 CASQ2 REN ITIH5 HMCN1 ENPEP	1.58e-04	147	282	9	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	CADM4 ITPR2 FREM2 CGN OLFM1 DNM1 NOS1 WNK3 DSE COL6A3 TRPC7 KIF27 GPR37 FAT3 RNF213 CPE CACHD1 TFDP2 IER2 TGM3 HMCN1 SCMH1 PLXNA4 CDH10	1.74e-04	797	282	24	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	SMG1 SP3 RIPOR2 ZBTB20 DOCK11 PRND F13A1 FZD4 PKHD1 PCDH10 ANAPC5 COL6A1 COL6A2 RC3H2 FAT3 REN RBM39 ITIH5 MTCP1 SCMH1 GMEB1 LRP6 TNXB ENPEP	1.81e-04	799	282	24	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	EPHB2 DPF1 BRINP3 ZBTB20 TAOK3 FAT1 DST CHD6 PCDH10 MPP3 FAT3 HECTD4 CPE RFX5 IFIT3 SLC5A2 TRIM9 SCMH1 CNTNAP2 SAMD14 PPP6R2	2.05e-04	658	282	21	Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	RIPOR2 DSE COL6A1 COL6A3 FAT3 CASQ2 REN ITIH5 HMCN1 ENPEP	2.48e-04	191	282	10	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100	FAT3 CASQ2 REN ENPEP	2.62e-04	24	282	4	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_100
CoexpressionAtlas	ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000	NUDT18 INPP4A INPPL1 TRPM2 PRND ITGAV TENM2 F13A1 FZD4 SLITRK2 MYO3B BCAR3 PCDH10 MAML3 COL6A1 COL6A2 DNAH10 GPR37 RTN4RL1 CPE ARL4D CNTNAP2 SERTAD4 PLXNA4 ENPEP CDH10 KCNH5	2.70e-04	976	282	27	PCBC_ratio_DE_vs_SC_1000
CoexpressionAtlas	ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5	INPP4A TRPM2 PRND FZD4 SLITRK2 MYO3B BCAR3 PCDH10 MAML3 GPR37 RTN4RL1 CPE ARL4D CNTNAP2 PLXNA4 ENPEP CDH10 KCNH5	2.73e-04	529	282	18	ratio_DE_vs_SC_1000_K5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 MYO7B ABCA13 OBSCN FREM2 FAT1 SLITRK2 PKHD1 TLN2 PCDH10 DNAH10 FAT3 HMCN1 HYDIN	1.80e-11	184	287	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 MYO7B ABCA13 OBSCN FREM2 FAT1 SLITRK2 PKHD1 TLN2 PCDH10 DNAH10 FAT3 HMCN1 HYDIN	1.80e-11	184	287	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 MYO7B ABCA13 OBSCN FREM2 FAT1 SLITRK2 PKHD1 TLN2 PCDH10 DNAH10 FAT3 HMCN1 HYDIN	1.80e-11	184	287	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 ABCA4 DOCK11 ABCA13 FAT1 PKHD1 FAT3 CPE PDXK CELSR1 SLCO1A2 ANKRD33B HYDIN	2.25e-10	183	287	13	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 FAT3 CPE PDXK CELSR1 SLCO1A2 ANKRD33B HYDIN	2.79e-09	183	287	12	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 MYO7B FAT1 PKHD1 DNM1 DOCK8 SLCO1A2 ANKRD33B ENPEP HYDIN CUX1	3.36e-09	186	287	12	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZBTB20 FREM2 DST PKD1 COL6A1 COL6A2 LAMA5 CPE TRIM9 SNTG1 MDGA1 CDH15	6.06e-09	196	287	12	b8b9801181d7604871b48aebacb295d0a57a5eaf
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DOCK11 TRPC4 FAT1 SLITRK2 COL6A1 COL6A2 COL6A3 COL6A6 CPE CDH19 CSPG4 LRP6	7.60e-09	200	287	12	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 FAT3 CPE PDXK SLCO1A2 ANKRD33B HYDIN	2.12e-08	176	287	11	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 PKHD1 FAT3 CPE PDXK CELSR1 SLCO1A2 ANKRD33B HYDIN	2.83e-08	181	287	11	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 DOCK8 FAT3 CPE SLCO1A2 ANKRD33B HYDIN	2.83e-08	181	287	11	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BRINP3 TENM2 ITPR2 OLFM1 COL6A1 FAT3 PLXNA4 ANKRD33B ENPEP CUX1 KCNH5	3.35e-08	184	287	11	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 PKHD1 FAT3 CPE PDXK CELSR1 SLCO1A2 BCAM HYDIN	3.35e-08	184	287	11	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	EXTL3 ITPR2 TAOK3 TLN2 MAML3 HECTD4 LLGL2 SCMH1 SNTG1 PPP6R2 CUX1	3.74e-08	186	287	11	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	EXTL3 ITPR2 TAOK3 TLN2 MAML3 HECTD4 LLGL2 SCMH1 SNTG1 PPP6R2 CUX1	3.74e-08	186	287	11	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 MALT1 FAT1 PKHD1 DNM1 DOCK8 CELSR1 SLC47A1 ANKRD33B ENPEP CUX1	3.96e-08	187	287	11	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	facs-Heart-RA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 GPR182 ITPR2 PIK3C2B DOCK6 NOS3 CPE HMCN1 BCAM SLC12A7 IPO11	4.18e-08	188	287	11	4ddb11a90bf3baa7237bde304db44dfcc56aed52
ToppCell	facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPOR2 GPR182 ITPR2 PIK3C2B DOCK6 NOS3 CPE HMCN1 BCAM SLC12A7 IPO11	4.18e-08	188	287	11	e47e66906922d5c69b1aafe28face0787d3fc563
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 FAT3 CPE PDXK CELSR1 SLCO1A2 HYDIN	4.41e-08	189	287	11	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Control / Disease state, Lineage and Cell class	DOCK11 DST ZNF589 C1QC HEATR5B DOCK8 SLC19A3 CPE PPARG CDCP1 SLC47A1	4.41e-08	189	287	11	937e876122bc4b94372a4104e9c1a9068c232018
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	DOCK11 DST ZNF589 C1QC HEATR5B DOCK8 SLC19A3 CPE PPARG ITIH5 SLC47A1	4.91e-08	191	287	11	a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	INPP4A SIDT1 IL18RAP EIF3CL SEC16A COL6A3 APMAP RNF213 IFIT3 BCAM MDGA1	7.09e-08	198	287	11	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 OBSCN KCNQ5 NOS2 ALOX15 DSC3 LAMA5 CACHD1 CELSR1 CROT BCAM	7.09e-08	198	287	11	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK11 TAOK3 FAT1 COL6A1 COL6A2 COL6A3 COL6A6 CDH19 CSPG4 LRP6 MDGA1	7.85e-08	200	287	11	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC4 DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 ITIH5 HMCN1 TNXB ENPEP	7.85e-08	200	287	11	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 MALT1 PKHD1 CPE SLCO1A2 ANKRD33B HYDIN	2.71e-07	137	287	9	0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 DOCK8 CPE SLCO1A2 ANKRD33B HYDIN	3.11e-07	182	287	10	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE2 EPPK1 FREM2 PKHD1 KIF27 FAT3 GRB7 CDCP1 LLGL2 PLET1	3.27e-07	183	287	10	2df1611c8acccb2a6f233d3d68bd9df2381a7278
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB1 FAT1 COL6A1 COL6A2 COL6A3 COL6A6 CPE CDH19 CSPG4 LRP6	3.44e-07	184	287	10	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	RIPOR2 DOCK11 MYO7B ABCA13 FAT1 PKHD1 DOCK8 CPE ENPEP HYDIN	3.44e-07	184	287	10	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	DOCK11 DST ZNF589 C1QC BCAR3 DOCK8 SLC19A3 CPE PPARG SLC47A1	3.61e-07	185	287	10	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 FREM2 FAT1 PKHD1 DOCK8 CPE SLCO1A2 HYDIN	3.80e-07	186	287	10	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CADM4 ADGRB1 TTC34 FREM2 SLITRK2 CPE CDH19 ITIH5 CSPG4 SAMD14	3.99e-07	187	287	10	6f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAPH1 RC3H1 MAML1 LCMT2 PIK3C2B SEC16A MLH1 NOS3 SLC12A7 SAMD14	3.99e-07	187	287	10	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAPH1 RC3H1 MAML1 LCMT2 PIK3C2B SEC16A MLH1 NOS3 SLC12A7 SAMD14	3.99e-07	187	287	10	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	BRINP3 TENM2 DST TLN2 COL6A1 COL6A3 FAT3 ITIH5 HMCN1 TNXB	3.99e-07	187	287	10	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 SMG1 ZBTB20 MAPRE2 DYNC1H1 ARFGEF1 RNF213 RICTOR SIK3 RBM39	4.19e-07	188	287	10	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 RIPOR2 DOCK11 ABCA13 FAT1 PKHD1 FAT3 CPE SLCO1A2 HYDIN	4.85e-07	191	287	10	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB20 DOCK11 ITGAV MALT1 FAT1 PKHD1 DNM1 ANKRD33B HYDIN CUX1	4.85e-07	191	287	10	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RIPOR2 DOCK11 FAT1 CGN NOS1 PPARG SLC32A1 CNTNAP2 SLC47A1 ECE2	5.09e-07	192	287	10	67d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	BRINP3 TLN2 DNM1 COL6A1 COL6A2 COL6A3 COL6A6 CPE TNXB ENPEP	5.09e-07	192	287	10	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT1 DNM1 NLRP5 COL6A1 COL6A2 COL6A3 ITIH5 ZC3HAV1L SAMD14 TNXB	5.33e-07	193	287	10	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH23 TENM2 ADCY1 DST COL6A1 COL6A2 COL6A3 FAT3 HMCN1 TNXB	5.33e-07	193	287	10	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	TRPC4 TENM2 COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 TNXB ENPEP	5.33e-07	193	287	10	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPHB2 BRINP3 FZD4 TLN2 DNM1 COL6A1 COL6A2 COL6A6 CPE ENPEP	5.59e-07	194	287	10	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 TRPC4 CGN NOS1 PPARG SLC32A1 EYS CNTNAP2 SLC47A1 ECE2	5.59e-07	194	287	10	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	TRPC4 DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 TNXB ENPEP	5.86e-07	195	287	10	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC4 FZD4 C1QC MOCS2 CA4 COL6A3 CPE CSPG4 PLET1 ENPEP	6.74e-07	198	287	10	882710bd6215e299257dd3df234292db9a2823ba
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 FREM2 NOS2 ALOX15 SEMA4B DSC3 LAMA5 CACHD1 CELSR1 CROT	6.74e-07	198	287	10	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 OBSCN KCNQ5 ALOX15 DSC3 LAMA5 CACHD1 CELSR1 CROT BCAM	7.06e-07	199	287	10	94a7867e800df352731796de8c24cba133c29622
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DOCK11 TRPC4 TAOK3 FAT1 SLITRK2 COL6A1 COL6A2 CDH19 CSPG4 MDGA1	7.39e-07	200	287	10	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ABCA13 DST CGN NECTIN4 ALOX15 DSC3 LAMA5 CELSR1 LLGL2 BCAM	7.39e-07	200	287	10	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC4 COL6A1 COL6A2 COL6A3 COL6A6 FAT3 ARL4D HMCN1 TNXB ENPEP	7.39e-07	200	287	10	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	PATL2 INPP4A IL18RAP FCGBP COL6A2 USP28 APMAP RNF213 CD247 LLGL2	7.39e-07	200	287	10	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F13A1 C1QC PLD4 RC3H2 COL6A6 DEPDC1 ARG2 PPP6R2 CYTH4	1.11e-06	162	287	9	b502d6af6868425b5c919740e011330c0d3cf3b8
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 MYO3B PKHD1 C6 DNAH10 FAT3 CNTNAP2 PLXNA4 HYDIN	1.58e-06	169	287	9	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 ABCA4 DOCK11 ABCA13 FCGBP PKHD1 CPE PDXK SLCO1A2	1.66e-06	170	287	9	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA13 FZD4 MAN2B2 COL6A6 CPE REN ITIH5 HELZ2 PPP6R2	2.32e-06	177	287	9	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ABCA13 PKHD1 MAML3 FAT3 CPE PDXK CELSR1 HYDIN	2.32e-06	177	287	9	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	DOCK11 ITPR2 TLN2 APMAP SLC19A3 PPARG PDXK ITIH5 PLXNA4	2.32e-06	177	287	9	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPAMD8 RIPOR2 DOCK11 ABCA13 PKHD1 CPE PDXK BCAM HYDIN	2.43e-06	178	287	9	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	MYCBP2 DOCK11 ITPR2 APMAP SLC19A3 PPARG PDXK ITIH5 PLXNA4	2.43e-06	178	287	9	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 DOCK11 ABCA13 MALT1 PKHD1 CPE SLCO1A2 HYDIN	2.89e-06	136	287	8	82b1d6d839c0d0c68e0960549f688138479defcc
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE2 EPPK1 FREM2 PKHD1 KIF27 FAT3 GRB7 CDCP1 PLET1	3.18e-06	184	287	9	6388c47b7f1d8203e3069eba0e74107256dcae51
ToppCell	droplet-Heart-4Chambers-18m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPIRE2 EPPK1 FREM2 PKHD1 KIF27 FAT3 GRB7 CDCP1 PLET1	3.18e-06	184	287	9	d83ae1dc64aa1b27d3b524c137567418cc0ff8c6
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|tumor_Lung / Location, Cell class and cell subclass	SLITRK2 ALOX15 COL6A2 DSC3 CPE MST1 PLXNA4 TNXB KCNH5	3.18e-06	184	287	9	b0a251030d127858e68cf164be158f209a4d720f
ToppCell	Control-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	DPF1 SPIRE2 RIPOR2 EXTL3 OLFM1 NOS1 GRB7 PLXNA4	3.22e-06	138	287	8	b7920c9a28d28220e7e4b30cd91ba13d0548eb76
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DST COL6A1 COL6A2 COL6A3 COL6A6 ITIH5 HMCN1 TNXB ENPEP	3.48e-06	186	287	9	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 ABCA4 DOCK11 ABCA13 FCGBP PKHD1 CPE SLCO1A2 ANKRD33B	3.63e-06	187	287	9	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	primary_visual_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	BRINP3 ITGAV TENM2 COL6A1 LLGL2 TRIM9 MDGA1 ANKRD33B	3.78e-06	141	287	8	605d7b28e99c943f64b4095855a6f9f70e92cb09
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 ABCA13 PKHD1 CPE PDXK CELSR1 SLCO1A2 ANKRD33B HYDIN	3.80e-06	188	287	9	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	MYCBP2 CDH23 ITPR2 APMAP SLC19A3 RTN4RL1 PPARG PDXK PLXNA4	3.80e-06	188	287	9	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP4A ITGAV TENM2 DST SEC16A MIA3 CPE RBM39 CNTNAP2	3.80e-06	188	287	9	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	BRINP3 CA4 COL6A1 COL6A2 COL6A3 COL6A6 ARL4D KRT75 TNXB	3.80e-06	188	287	9	0e2d1b21f0a7ee306e7dae16fc8c19d16a467883
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM4 FAT1 COL6A1 COL6A2 COL6A3 CACHD1 TRIM9 TNXB ENPEP	3.96e-06	189	287	9	1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM4 FAT1 COL6A1 COL6A2 COL6A3 CACHD1 TRIM9 TNXB ENPEP	3.96e-06	189	287	9	14833feea8f80744a06ece73f813eaeff8c4dd61
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RIPOR2 ABCA13 ITGAV CPE IER2 ITIH5 SLCO1A2 SLC45A2 HYDIN	3.96e-06	189	287	9	bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM4 FAT1 COL6A1 COL6A2 COL6A3 CACHD1 TRIM9 TNXB ENPEP	3.96e-06	189	287	9	bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FREM2 MYO3B CGN BUB1 PKHD1 GRB7 DEPDC1 CELSR1 LLGL2	3.96e-06	189	287	9	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 TRPC4 CGN NOS1 SLC32A1 EYS CNTNAP2 SLC47A1 ECE2	4.14e-06	190	287	9	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK11 TRPC4 CGN NOS1 PPARG SLC32A1 CNTNAP2 SLC47A1 ECE2	4.14e-06	190	287	9	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC4 OBSCN FAT1 DOCK6 COL6A1 COL6A2 COL6A3 CDH19 CSPG4	4.14e-06	190	287	9	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC4 OBSCN FAT1 DOCK6 COL6A1 COL6A2 COL6A3 CDH19 CSPG4	4.14e-06	190	287	9	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 COL6A1 COL6A2 COL6A3 CASQ2 ITIH5 CSPG4 TNXB ENPEP	4.32e-06	191	287	9	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPHB2 BRINP3 DNM1 COL6A1 COL6A2 COL6A6 CPE TNXB ENPEP	4.51e-06	192	287	9	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RALGAPA1 SMG1 MAPRE2 COL6A3 ARFGEF1 RNF213 SIK3 RBM39 PPP1R15B	4.51e-06	192	287	9	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GPR182 C6 NOS1 NOS3 ASAP3 CPE MAP3K6 ARL4D HMCN1	4.51e-06	192	287	9	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCA13 ALOX15 NWD1 DNAH10 CACHD1 CELSR1 BCAM CCDC17 HYDIN	4.70e-06	193	287	9	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 DOCK11 ABCA13 FAT1 PKHD1 CPE PDXK SLCO1A2 BCAM	4.70e-06	193	287	9	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM4 FDPS NECTIN4 MOCS2 DOCK8 PPARG MAP3K6 TGM3 CROT	4.70e-06	193	287	9	55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB20 DOCK11 ABCA13 FAT1 PKHD1 CPE SLCO1A2 ANKRD33B HYDIN	4.70e-06	193	287	9	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	TENM2 DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 CNTNAP2	4.70e-06	193	287	9	acad568621ed677031797b8c2e34dafea798d681
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 ITIH5 HMCN1 ENPEP	4.90e-06	194	287	9	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB20 DOCK11 ABCA13 FREM2 FAT1 PKHD1 CPE ITIH5 SLCO1A2	4.90e-06	194	287	9	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	TRPC4 DST COL6A3 COL6A6 FAT3 ITIH5 HMCN1 PLXNA4 TNXB	5.11e-06	195	287	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SLC38A10 DST SEC16A DYNC1H1 MIA3 COL6A6 ARFGEF1 CPE	5.11e-06	195	287	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 TNXB ENPEP	5.11e-06	195	287	9	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DST COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 TNXB ENPEP	5.11e-06	195	287	9	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SLC38A10 DST SEC16A DYNC1H1 MIA3 COL6A6 ARFGEF1 CPE	5.11e-06	195	287	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DST TLN2 COL6A1 COL6A2 COL6A3 COL6A6 FAT3 HMCN1 TNXB	5.33e-06	196	287	9	bc94909f9b2dc08a59eef1914148b69720569c8f
Computational	Placenta genes.	EPHB2 TRPC4AP INPPL1 TRPM2 F13A1 SLC38A10 FCGBP MVP COL6A1 COL6A2 COL6A3 CAD GRB7 LAMA5 PDXK SLC5A2 LLGL2 CSPG4 PPP6R2 TNXB CDH15	2.58e-05	463	178	21	MODULE_38
Drug	candesartan cilexetil	MYH13 PPIG DST MYO3B TAP1 NOS3 COL6A1 COL6A2 COL6A3 MYO18A REN PPARG	2.80e-07	145	283	12	CID000002540
Drug	bosentan	TRPC4 TRPM2 PPIG PKD1 NOS1 NOS2 NOS3 TRPC7 REN ECE2	8.37e-07	106	283	10	CID000104865
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	NUDT18 KIAA0586 MAML1 EXTL3 MALT1 ZNF589 ALOX15 CA4 MAP3K6 CNTNAP2 GMEB1 PPP6R2 STAG3	1.28e-06	198	283	13	5028_DN
Drug	3-Bromo-7-Nitroindazole	NOS1 NOS2 NOS3	1.90e-06	3	283	3	DB01997
Drug	N-(3-(Aminomethyl)Benzyl)Acetamidine	NOS1 NOS2 NOS3	1.90e-06	3	283	3	DB02044
Drug	satraplatin	EXTL3 PPIG FEN1 MLH1 C6 CA4	5.88e-06	37	283	6	CID006918220
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	EPHB2 DPF1 NDOR1 TRPM2 ZNF589 MAPRE2 MPP3 IL17RC IFIT3 ARL4D SLCO1A2 CNTNAP2	7.10e-06	197	283	12	3361_UP
Drug	Trioxsalen [3902-71-4]; Up 200; 17.6uM; HL60; HT_HG-U133A	NDOR1 INPP4A BCAR3 NOS2 GRB7 CPE GTPBP1 MAP3K6 KHSRP SLCO1A2 SLC47A1 SAMD14	7.10e-06	197	283	12	2516_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	EPHB2 F13A1 C2CD2L COL6A2 ASAP3 DDX51 ECPAS CDCP1 TFR2 SLCO1A2 SLC45A2 BCAM	7.10e-06	197	283	12	5618_UP
Drug	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	NOS1 NOS2 NOS3	7.53e-06	4	283	3	DB02692
Drug	malabaricone B	NOS2 NOS3 ARG2	7.53e-06	4	283	3	CID000163001
Drug	N-Omega-Hydroxy-L-Arginine	NOS1 NOS2 NOS3	7.53e-06	4	283	3	DB03144
Drug	verapamil	ABCA4 MYH13 ABCA13 ADCY1 PPIG KCNQ5 RPTOR MYO3B PKD1 MVP NOS1 TAP1 NOS2 TAP2 NOS3 MYO18A REN SLCO1A2 KCNH5	1.36e-05	490	283	19	CID000002520
Drug	oroxylin A	PPIG NOS1 NOS2 NOS3 CPE	1.85e-05	27	283	5	CID005320315
Drug	Thioglycolates	NOS1 NOS2 NOS3 PPARG MST1	1.85e-05	27	283	5	ctd:D013864
Drug	BQ 123	GPR182 NOS1 NOS2 NOS3 REN SLCO1A2	2.16e-05	46	283	6	CID000123632
Drug	Selara	DST NOS1 NOS2 NOS3 VCP COL6A1 COL6A2 COL6A3 REN	2.71e-05	125	283	9	CID000150310
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	NUDT18 DPF1 MAML1 ADCY1 C2CD2L TLN2 DOCK6 ASAP3 DDX51 ERN2 CYTH4	3.17e-05	193	283	11	4322_UP
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A	BRINP3 INPP4A MALT1 PIK3C2B ZNF589 TLN2 DOCK6 GPR37 XK ERN2 SCMH1	3.33e-05	194	283	11	2213_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HG-U133A	ZBTB20 ALS2CL ZNF589 NOS1 COL6A1 GPR37 ASAP3 ERN2 SLC5A2 ARG2 SLC45A2	3.65e-05	196	283	11	347_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	EPHB2 RALGAPA1 ZBTB20 EXTL3 ALS2CL MAPRE2 MVP TFDP2 LLGL2 TTLL4 LRP6	3.65e-05	196	283	11	3118_DN
Drug	N-nitroso-L-arginine	NOS1 NOS2 NOS3	3.70e-05	6	283	3	CID000127762
Drug	NapNa	NOS1 NOS2 NOS3	3.70e-05	6	283	3	CID000128726
Drug	1-hexacosanol	NOS1 NOS2 NOS3	3.70e-05	6	283	3	ctd:C051942
Drug	ferutinin	PDE6B NOS1 NOS2 NOS3	3.78e-05	16	283	4	CID000354654
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A	EPPK1 ZNF589 ALOX15 CA4 MIA3 IL17RC ECPAS ERN2 KHSRP BCAM ENPEP	3.83e-05	197	283	11	4761_DN
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A	FZD4 FAT1 PIK3C2B NFE2 ZNF589 CPNE1 C6 NOS1 SMG5 USO1 ZFYVE26	3.83e-05	197	283	11	1763_UP
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A	EPHB2 PDE6B ALS2CL F13A1 ITPR2 CA4 COL6A1 ERN2 ITIH5 SLCO1A2 CNTNAP2	3.83e-05	197	283	11	2819_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	EPPK1 PSMD1 ITPR2 MALT1 MAPRE2 XK MACROH2A1 GTPBP1 LRP6 PPP6R2 ENPEP	3.83e-05	197	283	11	1012_DN
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A	TRPC4AP INPPL1 C2CD2L ZNF589 OLFM1 RC3H2 GRB7 CDCP1 GMEB1 ZFYVE26 ECE2	4.01e-05	198	283	11	1710_UP
Drug	AC1Q5S0Y	INPPL1 PPIG NOS1 NOS2 NOS3 REN PPARG SLCO1A2	4.42e-05	103	283	8	CID000005650
Drug	ptaquiloside	TRPC4 ITGAV FAT1 DST PCDH10 COL6A2 FAT3 CNTNAP2 TNXB	4.43e-05	133	283	9	ctd:C043680
Drug	ASA404	PPIG MLH1 NOS1 NOS2 NOS3 CA4	4.92e-05	53	283	6	CID000123964
Drug	20-HETE	PPIG NOS1 NOS2 NOS3 ALOX15 REN PPARG BCAM	5.43e-05	106	283	8	CID005283157
Drug	1-TRIM	NOS1 TAP1 NOS2 NOS3	6.23e-05	18	283	4	CID000001359
Drug	AC1NLRUC	NOS1 NOS2 NOS3	6.41e-05	7	283	3	CID004988604
Drug	AC1L1KRE	NOS1 NOS2 NOS3 CA4	9.68e-05	20	283	4	CID000005622
Drug	17-ODYA	GPR182 PPIG NOS1 NOS2 NOS3 ALOX15	9.97e-05	60	283	6	CID000001449
Drug	Pcme	COL6A1 COL6A2 COL6A3	1.02e-04	8	283	3	CID000169849
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	EPHB2 NUDT18 FZD4 DOCK6 MVP DSE COL6A1 DSC3 ARG2 TRIM9	1.28e-04	188	283	10	2208_UP
Drug	12(S)-hydroxyeicosatetraenoic acid	ITGAV ADCY1 PPIG DST PIK3C2B ALOX15 COL6A1 COL6A2 COL6A3 REN	1.34e-04	189	283	10	CID000001413
Drug	L-Arginine	NOS2 NOS3 ARG2	1.51e-04	9	283	3	DB00125
Drug	Vi-o	NOS1 NOS2 NOS3	1.51e-04	9	283	3	CID005289554
Drug	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	NOS1 NOS3	1.54e-04	2	283	2	DB01821
Drug	N,N-dimethylarginine	NOS2 NOS3	1.54e-04	2	283	2	DB01686
Drug	6 Ni	NOS2 NOS3	1.54e-04	2	283	2	CID000024239
Drug	N-Omega-Propyl-L-Arginine	NOS1 NOS2	1.54e-04	2	283	2	DB02644
Drug	S-Ethyl-N-Phenyl-Isothiourea	NOS1 NOS3	1.54e-04	2	283	2	DB03707
Drug	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	NOS1 NOS3	1.54e-04	2	283	2	DB08018
Drug	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	NOS1 NOS3	1.54e-04	2	283	2	DB08019
Drug	3 h x	NOS2 NOS3	1.54e-04	2	283	2	CID016058621
Drug	DB02077	NOS2 NOS3	1.54e-04	2	283	2	CID000656912
Drug	AC1LCVOW	NOS2 NOS3	1.54e-04	2	283	2	CID000656910
Drug	5-nitroindazole	NOS2 NOS3	1.54e-04	2	283	2	CID000021501
Drug	AC1NRAON	NOS2 NOS3	1.54e-04	2	283	2	CID005288020
Drug	DB07388	NOS2 NOS3	1.54e-04	2	283	2	CID011149707
Drug	neoquassin	PPIG SLC45A2	1.54e-04	2	283	2	CID000072964
Drug	AC1L96OZ	NOS2 NOS3	1.54e-04	2	283	2	CID000439092
Drug	AC1NRAUH	NOS2 NOS3	1.54e-04	2	283	2	CID005288100
Drug	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	NOS2 NOS3	1.54e-04	2	283	2	DB07388
Drug	NSC-10379	NOS2 NOS3	1.54e-04	2	283	2	CID000223131
Drug	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	NOS3 REN	1.54e-04	2	283	2	DB07244
Drug	hard metal	NOS2 NOS3	1.54e-04	2	283	2	ctd:C080121
Drug	Ethylisothiourea	NOS2 NOS3	1.54e-04	2	283	2	DB02234
Drug	7-Nitroindazole	NOS2 NOS3	1.54e-04	2	283	2	DB02207
Drug	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	NOS1 NOS3	1.54e-04	2	283	2	DB02077
Drug	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	NOS1 NOS2	1.54e-04	2	283	2	DB03449
Drug	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	NOS1 NOS3	1.54e-04	2	283	2	DB02027
Drug	5-Nitroindazole	NOS2 NOS3	1.54e-04	2	283	2	DB04534
Drug	6-Nitroindazole	NOS2 NOS3	1.54e-04	2	283	2	DB03100
Drug	soyasaponin II	NOS2 REN	1.54e-04	2	283	2	ctd:C106126
Drug	Nitroarginine	NOS1 NOS3	1.54e-04	2	283	2	DB04223
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	EPHB2 PDE6B EXTL3 MVP NOS1 COL6A1 ECPAS CNTNAP2 LRP6 STAG3	1.59e-04	193	283	10	5584_DN
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	INPP4A OSGEPL1 ZNF589 BUB1 DOCK6 ANAPC5 ALOX15 CPE ERN2 STAG3	1.66e-04	194	283	10	898_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	CEP104 EPPK1 ADCY1 MPP3 DSC3 ASAP3 PPARG ERN2 IER2 TRIM9	1.66e-04	194	283	10	1226_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A	C2CD2L FZD4 DOCK6 SLC27A5 MIA3 RFC2 PDXK SCMH1 BCAM PPP6R2	1.66e-04	194	283	10	1947_DN
Drug	cilazaprilat	NOS1 NOS2 NOS3 REN	1.72e-04	23	283	4	CID000064766
Drug	Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	ZBTB20 INPP4A MAML1 DOCK6 GRB7 DDX51 CDH19 SLC5A2 TTLL4 CYTH4	1.73e-04	195	283	10	4203_UP
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	EPHB2 RALGAPA1 NDOR1 INPP4A ITPR2 ZNF589 RALGAPB IL17RC SLC47A1 PPP6R2	1.73e-04	195	283	10	5399_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	KIAA0586 XAB2 ITPR2 MALT1 TAOK3 GPR37 RALGAPB ARFGEF1 TLN1 BCAM	1.73e-04	195	283	10	5004_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	CEP104 EPPK1 KIAA0586 SIDT1 LCMT2 OSGEPL1 LAMA5 TFDP2 IER2 STAG3	1.73e-04	195	283	10	6973_DN
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A	ADGRB1 CA4 COL6A1 DSC3 CDCP1 KRT75 TTLL4 CNTNAP2 SLC45A2 CDH15	1.73e-04	195	283	10	6104_UP
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A	ZBTB20 INPP4A ADCY1 TLN2 NOS1 MPP3 VHL ASAP3 CDH19 ERN2	1.80e-04	196	283	10	5097_UP
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	XAB2 CPNE1 ANAPC5 MVP ARFGEF1 GRB7 SMG5 ERN2 TTLL4 LRP6	1.80e-04	196	283	10	4834_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A	EPHB2 EPPK1 ANAPC5 RC3H2 ERN2 TFDP2 KRT75 TLN1 CNTNAP2 BCAM	1.80e-04	196	283	10	5860_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NUDT18 TRPC4AP INPP4A ALS2CL INKA2 PIK3C2B ZNF589 CA4 ERN2 PPP6R2	1.80e-04	196	283	10	2764_DN
Drug	1,5-Isoquinolinediol; Up 200; 100uM; HL60; HG-U133A	EPHB2 ZBTB20 INPP4A C2CD2L FZD4 ZNF589 NOS1 RALGAPB ERN2 CYTH4	1.88e-04	197	283	10	543_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; PC3; HT_HG-U133A	EPHB2 ZBTB20 PDE6B INPP4A ADCY1 TELO2 MPP3 GRB7 SLC5A2 PPP6R2	1.88e-04	197	283	10	4588_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; MCF7; HT_HG-U133A	EPHB2 CADM4 ADGRB1 INKA2 ITPR2 ASAP3 IL17RC KHSRP CNTNAP2 SAMD14	1.88e-04	197	283	10	3836_UP
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A	EPHB2 ALS2CL BUB1 OLFM1 NOS1 IL17RC ECPAS ERN2 TTLL4 SLC12A7	1.96e-04	198	283	10	4150_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	DPF1 INPP4A BUB1 COL6A1 COL6A3 GPR37 ASAP3 ECPAS SNTG1 BCAM	1.96e-04	198	283	10	6395_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	EPHB2 INPPL1 C2CD2L ZNF589 ANAPC5 MVP COL6A1 ERN2 KRT75 BCAM	1.96e-04	198	283	10	5852_DN
Drug	Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	EPHB2 INPP4A ALS2CL ZNF589 BUB1 ALOX15 MPP3 COL6A1 DDX51 LRP6	1.96e-04	198	283	10	3876_DN
Drug	4-phenylimidazole	GPR182 NOS1 NOS2 NOS3	2.04e-04	24	283	4	CID000069590
Drug	Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; HL60; HT_HG-U133A	INPP4A PIEZO1 ALS2CL INKA2 DOCK6 DDX51 KHSRP TFR2 CSPG4 SAMD14	2.04e-04	199	283	10	2966_UP
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	RALGAPA1 INPP4A ADGRB1 MAPRE2 GPR37 KHSRP CELSR1 SLCO1A2 TLN1 SLC47A1	2.04e-04	199	283	10	2320_UP
Drug	hydroethidine	ITGAD NOS1 NOS2 NOS3 SLC47A1	2.09e-04	44	283	5	CID000065410
Drug	Ethamivan [304-84-7]; Up 200; 18uM; HL60; HG-U133A	TRPC4AP ZNF589 CPNE1 C6 MAPRE2 ITIH5 ARG2 TLN1 CUX1 ECE2	2.13e-04	200	283	10	1730_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	EPHB2 PDE6B INPP4A PRND EXTL3 INKA2 MALT1 BUB1 MAPRE2 CNTNAP2	2.13e-04	200	283	10	3538_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NUDT18 TRPC4AP RIPOR2 TRPM2 F13A1 MAPRE2 CA4 ECPAS SLC5A2 SLC45A2	2.13e-04	200	283	10	4975_UP
Disease	Ullrich congenital muscular dystrophy 1	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	cv:C4551860
Disease	Bethlem myopathy	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	C1834674
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A1 COL6A2 COL6A3	3.32e-06	4	279	3	DOID:0050558 (is_implicated_in)
Disease	employment status	KLF15 ADAM32 PLXNA4 IPO11	9.84e-06	15	279	4	EFO_0005241
Disease	congenital muscular dystrophy (implicated_via_orthology)	DYNC1H1 COL6A1 COL6A3	1.64e-05	6	279	3	DOID:0050557 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CPAMD8 ABCA4 ABCA13 OBSCN FZD4 FAT1 KCNQ5 BUB1 FEN1 PKHD1 MLH1 CAD MYOT ASAP3 ARFGEF1 CPE PPARG SLCO1A2 CUX1	4.53e-05	702	279	19	C0009402
Disease	alpha-linolenic acid measurement	UBXN4 CEP120 FEN1 NLRP5	8.46e-05	25	279	4	EFO_0007759
Disease	Ullrich congenital muscular dystrophy (implicated_via_orthology)	COL6A1 COL6A3	8.91e-05	2	279	2	DOID:0050558 (implicated_via_orthology)
Disease	urea measurement	TGM3 CNTNAP2 SLC45A2	9.55e-05	10	279	3	EFO_0011005
Disease	lissencephaly (implicated_via_orthology)	NOS1 NOS2 NOS3 DYNC1H1	1.16e-04	27	279	4	DOID:0050453 (implicated_via_orthology)
Disease	primary biliary cholangitis (biomarker_via_orthology)	NOS2 NOS3 REN SLCO1A2	1.34e-04	28	279	4	DOID:12236 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LENVISNAVPGRRQN	BANP	146	Q8N9N5
PTRELVVNAVTLFGN	ALS2CL	181	Q60I27
VNNLAVERRNFLGSP	BRINP3	86	Q76B58
IPQAGQAELFLRLVN	CCDC17	531	Q96LX7
VANQASLPLVDFIIQ	ASAP3	596	Q8TDY4
IVNPRSVGLANQELA	ARG2	86	P78540
RASDNQGVPVLVLAN	ARL4D	121	P49703
VLQRGIQNQAEPREF	BUB1	121	O43683
DVLFQVTQFPSRGQL	CSPG4	1746	Q6UVK1
RSQVQAEAPVGIYLQ	ABCA4	621	P78363
ISQQSGAIIFQPINR	BCAR3	241	O75815
PGDVQNFVQILSNLL	ADGRB1	706	O14514
ILTNGFAVLETVNPQ	AFTPH	181	Q6ULP2
QSPGILRLQFQVLVQ	CDCP1	321	Q9H5V8
RENPGQSLNRLFQEV	CUX1	631	P39880
LSILQNAGPIFRTNE	ARFGEF1	461	Q9Y6D6
LRLPFLDSQTGVAQN	DPF1	36	Q92782
PIFQISNVTGENLDL	GTPBP1	361	O00178
NLAGFEVEAIINPTN	MACROH2A1	206	O75367
RSAVFQQPVIFLGAD	AGO1	581	Q9UL18
LARIPGTNAFVGIVN	CACHD1	926	Q5VU97
FQNIIAVQDISLGIP	ABCA13	4731	Q86UQ4
IPLTGFVARVQENIA	ABI1	376	Q8IZP0
FGSQRPLLDSVAQQQ	COMMD5	131	Q9GZQ3
ASRPGFQNSLLQIVI	ADAM32	16	Q8TC27
VLLDQLRFPNGVQLS	APMAP	251	Q9HDC9
EANVNILTRNGESPI	ANKRD61	301	A6NGH8
LVFVIGINQTENPFL	CELSR1	2516	Q9NYQ6
GERDPINLQVLQAFV	CYTH4	116	Q9UIA0
RPQALARQLDVFGQA	DEDD2	221	Q8WXF8
FRIQGNQLFLNVTPD	CDHR5	71	Q9HBB8
LQQVAPEATVRRFLQ	DIPK1B	316	Q5VUD6
AQVGFALPLFIQVVD	CDH23	361	Q9H251
FQLRQGPDQVQSLEA	ADAMTS10	776	Q9H324
AVQEILAARAARGPQ	ANKRD33B	341	A6NCL7
SGVVLVFPLNSRQDV	NWD1	1276	Q149M9
VNFALLQLVGAQVPD	RC3H2	66	Q9HBD1
GIPVDSERVFLQNNR	RTN4RL1	51	Q86UN2
VNSALLQLVGAQVPE	RC3H1	66	Q5TC82
QRVLGVPIIVQASQA	RBM39	216	Q14498
VQPGFLADLNRTLQR	RAPH1	1161	Q70E73
IAENNPRGASIFLVT	PCDHGA7	461	Q9Y5G6
VNNLGSLVARLIFQP	RFT1	281	Q96AA3
GANNLQVNALVARLP	RFX5	316	P48382
NRGIAIPVDLDSQVN	ITPR2	1546	Q14571
PVLFNVGINEQQTLA	INPP4A	796	Q96PE3
PRQLFEIAIQAAIGS	GUF1	591	Q8N442
IPRGSVQFAQEIDQV	KIAA1107	851	Q9UPP5
NLAFAQLILGIPEQA	ANAPC5	626	Q9UJX4
GFNVRPREAQVQLNV	MDGA1	521	Q8NFP4
NNGNIRSAITVFPQR	NOS2	236	P35228
AFIVENLPGGSRVIQ	FAT1	2816	Q14517
QNAQRALAGVVLPSQ	MAML1	371	Q92585
IPNFIQSQDFLEGLQ	OGFOD1	66	Q8N543
RDLLPQNNAVLVASG	OSGEPL1	311	Q9H4B0
NVTEFILIGLTQNPI	OR4C12	6	Q96R67
VLENNPRGASIFSVN	PCDHGA6	461	Q9Y5G7
VNGPSIFELQAAVNL	IL18RAP	486	O95256
IQLQFQPLAADGILF	EYS	2741	Q5T1H1
GNVFVVQLPAFRALE	LLGL2	151	Q6P1M3
VNQFQGSPQDIAAVR	MAML3	801	Q96JK9
GVQQRLIQAPFQVTD	GMEB1	286	Q9Y692
PTVVQQARIAQNGIL	ITIH5	241	Q86UX2
QPQELGRRFALTANI	INKA2	196	Q9NTI7
VLLDTSIGPLQFAQQ	MGAM2	191	Q2M2H8
EIPNGNTSELIFNAV	MALT1	166	Q9UDY8
NVLVTVAFRSPGIQD	NUDT18	271	Q6ZVK8
QDQFLGIAAINISLP	DST	2276	Q03001
PLVNRLQDAFSAIGQ	DNM1	11	Q05193
LLTAPQGNVDLVRFT	FDPS	241	P14324
EVRQALGQVPDGFVQ	ERN2	866	Q76MJ5
RAGLITNFNEPINQI	IPO11	91	Q9UI26
RGLQFILTPNEFSAQ	KCNQ5	686	Q9NR82
VNGIPAEQFTQRDIL	FREM2	996	Q5SZK8
RGLVAPQNTFLENIV	KCNH5	6	Q8NCM2
TARANNPGIVLTFVL	DDX56	376	Q9NY93
NSNVIQVDQSGLFLP	ECE2	291	P0DPD6
NVIATRAGEQLAPFL	ECPAS	1106	Q5VYK3
GAQILANDPTQVVLA	MAP3K6	446	O95382
RVYQPGQITDRAVLN	EFHC2	291	Q5JST6
LRQNDGQFTVIQLVG	EPHB2	711	P29323
IPNSQQVIIGRDRVF	KIF27	31	Q86VH2
LNIQGSEQRVPALRF	PLXNA4	741	Q9HCM2
PTIINGNATRFSQIL	MYO18A	546	Q92614
NGVAELATRLFSVQP	PDE6B	101	P35913
NQNAGNIVVSRLDPV	OLFM1	371	Q99784
RVLNPQGTLIQFSDE	CSKMT	186	A8MUP2
IQQFFPTSERDIQGL	CSNKA2IP	556	A0A1B0GTH6
QALNGQQTLSPEEFI	GUCA1C	121	O95843
AQENQQIGRVEFLPV	DDHD2	256	O94830
LLRNNSNFGPEVTRQ	DEPDC1	56	Q5TB30
QFLNGANPVVLRRSA	ALOX15	231	P16050
QDRGFPVSLQARDQV	ALOX15	511	P16050
DSNILQPVGLTVFEN	LRP6	1141	O75581
ILPGFQRTVAIADSN	DSE	301	Q9UL01
VPRGVNLQEFLNVTS	F13A1	36	P00488
TILSDVNPRNTFGQL	KCNU1	971	A8MYU2
LQLQDVVGESVAPFN	NLRP5	481	P59047
NRNLGRIVTIAEPFN	ENPEP	886	Q07075
CISNVFVQRLLGPQR	LAMA5	3261	O15230
PQALAGNATVNILIV	PCDH10	551	Q9P2E7
VVENGVFVANPLQER	HECTD4	51	Q9Y4D8
IEILGFQPSNQLSAI	RICTOR	1526	Q6R327
VDGLFLVRESQRNPQ	GRB7	451	Q14451
LVRESQRNPQGFVLS	GRB7	456	Q14451
VANPVSRDAQGLVLF	MVP	61	Q14764
VQNNLPRDLLTGEQF	PRPF39	251	Q86UA1
GVAPFRAAIQERVAQ	NDOR1	461	Q9UHB4
GTNFPNEVSVVLNRD	HMCN1	1456	Q96RW7
RQSLDFILSQPQLGQ	MOGAT3	171	Q86VF5
FGVQQIQPNVISVRL	NOS1	6	P29475
QSFSLQERQLRGAVP	NOS3	1176	P29474
LSFQNVDPLGENIRV	PIK3C2B	1066	O00750
FFDIAINNQPAGRVV	PPIG	11	Q13427
INNQPAGRVVFELFS	PPIG	16	Q13427
RLVVGAPLEVVAANQ	ITGAD	46	Q13349
DQQPVAAGARFRLAQ	OBSCN	46	Q5VST9
AQPAGATVQEQLRQL	PLD4	466	Q96BZ4
RPVTVVLQNQFGISL	PATL2	446	C9JE40
SLIRFNAVLTNPQGD	C1QC	136	P02747
ILFANPNIFVGENIL	EIF3C	411	Q99613
NQNLDALTGFVVAPL	FZD4	381	Q9ULV1
DILFANPNIFVGENI	EIF3CL	411	B5ME19
VPQLQQVGQLALLFS	ADCY1	116	Q08828
NQVALVAINIIGDPA	CEP104	141	O60308
QFLIAVRQGGDVLQN	FEN1	41	P39748
VLEAVANSNNIPGIR	HYDIN	2071	Q4G0P3
NRPASNIELLAVQEG	HEATR5B	1941	Q9P2D3
RGNPTALQLFLQISE	GPR37	136	O15354
VNEGFQPLVEALSNI	CA4	176	P22748
GRIITFEQQLPVSAN	DOCK11	766	Q5JSL3
TVNQGPLEVAQVFLA	DOCK6	1941	Q96HP0
NQGPLEVAQVFLAEI	DOCK8	1986	Q8NF50
EGAFPVTQNRALQLL	COG1	796	Q8WTW3
VNLEIGVNNEAPFAR	DSC3	431	Q14574
RNGSSIQIAFEEVPQ	C2CD2L	116	O14523
RVPANLENVGFEVQT	C6	231	P13671
TGQQRPERASLQFLQ	COL6A1	881	P12109
FVCENARPGQLIQTI	CDH10	496	Q9Y6N8
SLEVANQTPGLQRAF	CHD6	1916	Q8TD26
VPVIAAQGSNNRIAD	CEP120	581	Q8N960
ILQAQLPITEAQSFG	CD247	11	P20963
QTPGFSLQQLRFLII	DDX51	356	Q8N8A6
LPFQAADGQVQVFRQ	FCGBP	951	Q9Y6R7
QAALGGNVPREQFTV	EXTL3	651	O43909
FQLLVSLQEPEAQGR	CPAMD8	1506	Q8IZJ3
SIPLQADFIGVVRNN	ITGAV	676	P06756
TQQIRVGVVQFSDEP	COL6A3	276	P12111
VAIPTFRQLGTVQQV	COL6A3	1186	P12111
REEGIRLFAVAPNQN	COL6A2	181	P12110
VAIVNAVGNRLNEPL	FAT3	2001	Q8TDW7
INNVIDNLIVAPGTF	ILF2	81	Q12905
IELFQRVLESTPNNG	IFIT3	261	O14879
RDLQGNPIANATISV	CPE	381	P16870
GSIVVIQNPARQTLF	CADM4	51	Q8NFZ8
LAGFQQFLQSLQPRT	DDX12P	546	Q92771
NDIIQDNNGTIIPFR	MAPRE2	16	Q15555
QPVTVNLEAVLQALG	MAN2B2	931	Q9Y2E5
PELIQQFLQATVSGL	IPO9	511	Q96P70
VEDPTFLNQLQSGVN	DYNC1H1	236	Q14204
LLVNIQGQTFALVPQ	KLF15	251	Q9UIH9
EIQGFFNIPVDNLRA	PRPSAP2	151	O60256
LFRPQIGVVNVTDAD	CASQ2	326	O14958
VPGRLNQDLFSVSFQ	CNTNAP2	386	Q9UHC6
SPLNDFQVLRGTELQ	MST1	21	P26927
FCEAQQTLVPAGQVR	HELZ2	2626	Q9BYK8
RTQNFTLLVQGSPEL	BCAM	436	P50895
IRLGSVQQPSSDFNI	C4orf54	1031	D6RIA3
EQLGFTVPELARNVA	DNAH10	681	Q8IVF4
RVFNGLVLTNPERFQ	DNAH10	2661	Q8IVF4
FLPTRLQAQQDAVNI	PSMD4	21	P55036
QAIARDGIVPFLQVF	SLC12A7	531	Q9Y666
VDQRGLNLPVSIQFL	SLC19A3	426	Q9BZV2
LNGATVVAALIANPR	SLC45A2	121	Q9UMX9
RPQAVLSEQQNGLAV	SLC38A10	606	Q9HBR0
NAALRFSILQQGSPE	CDH15	186	P55291
PSQVVRNAALFALGQ	IPO4	406	Q8TEX9
FQTINLNRNVERAVP	KCTD3	671	Q9Y597
ILTNRTGFNLQEEPV	CDH19	531	Q9H159
PDRVQIGVVQFSDIN	COL6A6	656	A6NMZ7
RSGQAAARDIVQFVP	CPNE1	471	Q99829
LEVQVPAALVQFGQS	IL17RC	211	Q8NAC3
TRIANAVVQNLERGP	PPP6R2	481	O75170
QETLDVGSFQRLPQL	FAM166A	191	Q6J272
LDVRIPSQLNVNFAG	CROT	91	Q9UKG9
GNVTLQPERQFVQLG	PKD1	1381	P98161
ALQQAADGTIFLVPR	NFE2	351	Q16621
VNQPFEINAITGEIR	PCDHB6	286	Q9Y5E3
QAEGAFPNLARVLQR	IER2	166	Q9BTL4
GLPFQRRQVLEVVSQ	MPP3	251	Q13368
NQQTGAFVEISRQLP	KHSRP	451	Q92945
FRLRQVVRGAPAEQQ	RUNDC1	106	Q96C34
PGLADVRNQIIFAVR	MOCS2	46	O96033
SANVPFLTGQIAENL	USO1	516	O60763
EVRLEQQSVPAAVFG	XAB2	836	Q9HCS7
RVLQQPVFLATGAVQ	SUPT20HL1	781	Q3ZLR7
PLVIGQFLEAVDQNT	PSMC4	86	P43686
INQAALLSIPGFVER	TRPC4AP	286	Q8TEL6
IARLQGSILQFNPEV	SMG5	776	Q9UPR3
GRQFDVNLQVPDRAV	MIA3	751	Q5JRA6
QQLPAFLELAQQLGV	FAM83E	191	Q2M2I3
RNLVSNQILTFQGPF	FER1L5	1086	A0AVI2
NQILTFQGPFIRVVF	FER1L5	1091	A0AVI2
RARVQQIQVPLGDAA	MTCP1	41	P56278
PGTDLSRQNAFQVIA	SNTG1	221	Q9NSN8
QAIGRVTPIFDNIIS	REN	201	P00797
VFNVLTACRLRQPGQ	GPR182	236	O15218
IPGFVNLDLNDQVTL	PPARG	331	P37231
TADFVRQLLIGLPNQ	SMG1	3086	Q96Q15
SGFLVDPLNNQRLSV	EPPK1	1286	P58107
QAATGFVIDPVRNLR	EPPK1	2266	P58107
AQAATGFVIDPVRNL	EPPK1	2801	P58107
AQAATGFVIDPVRNL	EPPK1	3866	P58107
QAATGFVIDPVRNLR	EPPK1	4401	P58107
IEELQIFSSGQPVQN	SEMA4B	486	Q9NPR2
TNDPVNYVRQGALIA	PSMD1	676	Q99460
LAGFLIRNIPVINDN	SLC9B2	151	Q86UD5
LGNNRIAVIQEGAFT	SLITRK2	406	Q9H156
IQEQNVALNFIGSRG	POLR2B	311	P30876
VQTSQGVPVRRFQTL	INPPL1	81	O15357
PRALAFQAPVNIQAE	SIK3	401	Q9Y2K2
ILFQETRNGPLNESQ	TAOK3	311	Q9H2K8
CRQQTQPGFILLRET	TELO2	141	Q9Y4R8
QEPQVFGRSLQENIA	TAP1	586	Q03518
QEPVLFSGSVRNNIA	TAP2	551	Q03519
EFAARQVDGPQLLQL	SAMD14	346	Q8IZD0
ENPFNSSLVSLIRGQ	TENM2	921	Q9NT68
FGLVQQLLPSVAILN	MYCBP2	1971	O75592
NFIRVSDENLTGVNP	PKHD1	861	P08F94
NIQIQPDVSCRGRLF	PKHD1	2956	P08F94
QIERQFNIPTSLVGF	SLCO1A2	46	P46721
ALSPFERVQNVLQDG	SLC25A53	131	Q5H9E4
VRLNSVGQPVFLSQF	METTL22	36	Q9BUU2
PANEIFVTNVRSLGV	SERTAD4	261	Q9NUC0
VNRIAAGEVIQRPAN	MLH1	16	P40692
GPLNIQRIDNFSVVS	PPP1R15B	206	Q5SWA1
NRAATFPLQVLGFEI	PDXK	21	O00764
AGQEDVLFPVARAQV	AARS2	581	Q5JTZ9
TNAEVRGFIDQNLSP	TFDP2	11	Q14188
TRLDDQIFLNRNPGV	RPTOR	1011	Q8N122
AARPQVVAVDINDLG	RIPOR2	291	Q9Y4F9
PQIVTGVAANLVNAL	SLC47A1	186	Q96FL8
GPARASVVLQQAVQA	SCMH1	386	Q96GD3
VLQQPVFLATGAVQI	SUPT20HL2	776	P0C7V6
QVLDATPQERSQGVF	TGM3	351	Q08188
RVQGIAGQPFVVLNS	CGN	56	Q9P2M7
IRLEGLANQVFSSPI	PLET1	176	Q6UQ28
DIFQQTPLGRFLAQL	RNF213	3741	Q63HN8
FLNAPRVEAQVLLGS	RALGAPA1	1226	Q6GYQ0
SARPQELVGTFIQQE	SEC16A	536	O15027
LSFGPQQLQNRDLVV	STAG3	966	Q9UJ98
FVLALFVPRVNEQGA	SLC5A2	471	P31639
NVFIIGATNRPDIID	VCP	616	P55072
GIVVDPLFVLDNRAQ	SLC27A5	656	Q9Y2P5
PSAFILRAIQQAVGS	SCAF1	31	Q9H7N4
AAVSQQLAPREGISQ	TLN1	1681	Q9Y490
TAPIQRRDIFQSLQG	SPIRE2	631	Q8WWL2
LQLNPGTFLIQAQTV	SP3	441	Q02447
SGRVADVIAQVANLP	TRPM2	356	O94759
GIITVNDFTQNPRVQ	ROPN1	196	Q9HAT0
SPVVQEGQGTLRRQF	SPATA31D1	991	Q6ZQQ2
NETGPLQQLIFVDVA	SIDT1	136	Q9NXL6
ITEAQVAENRPGAFI	PRND	46	Q9UKY0
ELLVQFVQNTSIPLG	ZNF410	11	Q86VK4
VAANQREVTVQGLEP	TNXB	3401	P22105
RTNFFIQLVRPGVAQ	MRPL23	21	Q16540
NQTELFVPSLNVDGQ	VHL	131	P40337
QIIQANPLLEAFGNA	MYH13	221	Q9UKX3
EVFAREGNVPNIIIA	RFC2	61	P35250
NQLREITGIQDPSFL	USP28	26	Q96RU2
LFVPRQEQGSSQIRL	RALGAPB	126	Q86X10
SLPDQLVNRSIQQGF	SEPTIN10	51	Q9P0V9
QELQVTGPFNLQLIA	CAD	1191	P27708
RIVSQNVGDVFPGIQ	ZBTB20	191	Q9HC78
EGLFFPAVSLNRNVQ	TRIM9	676	Q9C026
QGLVDPIQFARANQA	TLN2	1461	Q9Y4G6
RIPGVQARDLFAQIA	TSSK6	106	Q9BXA6
TDNLPGSIRAVVNIF	SLC32A1	371	Q9H598
LPAQAVFASGTRQQL	PIEZO1	961	Q92508
LEQIGAPQAALRAQI	LCMT2	71	O60294
GNRILEIQLSPAQNA	ZNF589	181	Q86UQ0
NLVLRPFGLSTENFQ	TTC1	256	Q99614
PLEEARQFAAQTVGN	UBXN4	341	Q92575
QQFPQEDAGSVRRVL	TTLL4	386	Q14679
FNTVLRAEPGNVQAL	TTC34	201	A8MYJ7
NADGIRGFPVVLQQI	ZFYVE26	1016	Q68DK2
LQGRLPAVAQAVAQL	TFR2	611	Q9UP52
PAVAQAVAQLAGQLL	TFR2	616	Q9UP52
VIQAFLGSAPQLTLQ	XK	141	P51811
VARQQAAGPLERNIQ	TRPC4	871	Q9UBN4
SLPQLFIFAQRNVEG	AVPR2	171	P30518
QLFVDAGVPVNSNVI	KIAA0586	976	Q9BVV6
EGQRPQLTAAAENIL	KIAA0586	1326	Q9BVV6
QGVAFPISREAFQAL	TWF1	176	Q12792
FAQGQRLTLSPLEQE	TRPC7	131	Q9HCX4
LLQDQGLNIPSVVNF	ZC3HAV1L	221	Q96H79
SFQRGRFQVITIPQQ	WNK3	1331	Q9BYP7
EQGSRTVRQNLEPLF	KRT75	186	O95678
AFVRPVILQGLTDNS	JMJD8	61	Q96S16
VGDILIALNPFQNLS	MYO3B	376	Q8WXR4
VGFERLQAIARSQPL	MYO7B	811	Q6PIF6
ARRLLGPQNAAAVFQ	MYOT	186	Q9UBF9
NPLDGSVLLRNAVQA	NECTIN4	106	Q96NY8